Diabetes Technology and Therapeutics
Journal Impact IF - Analysis · Trend · Prediction · Ranking


New

Journal Impact IF

2019-2020

4.403

-1.9 %

Journal Impact IF Trend

Related Journals

Popular Journals

Diabetes Technology and Therapeutics

The 2019-2020 Journal Impact IF of Diabetes Technology and Therapeutics is 4.403, which is just updated in 2020.

Diabetes Technology and Therapeutics Impact Factor
Highest IF
4.488
Highest Journal Impact IF

The highest Journal Impact IF of Diabetes Technology and Therapeutics is 4.488.

Lowest IF
1.931
Lowest Journal Impact IF

The lowest Journal Impact IF of Diabetes Technology and Therapeutics is 1.931.

Total Growth Rate
128.0%
IF Total Growth Rate

The total growth rate of Diabetes Technology and Therapeutics IF is 128.0%.

Annual Growth Rate
14.2%
IF Annual Growth Rate

The annual growth rate of Diabetes Technology and Therapeutics IF is 14.2%.

Journal Impact IF Ranking

Subcategory Quartile Rank Percentile
Medical Laboratory Technology Q1 2/28

Medical Laboratory Technology 94%

Endocrinology, Diabetes and Metabolism Q1 26/217

Endocrinology, Diabetes and Metabolism 88%

Endocrinology Q1 17/118

Endocrinology 86%

Journal Impact IF Ranking

· In the Medical Laboratory Technology research field, the Quartile of Diabetes Technology and Therapeutics is Q1. Diabetes Technology and Therapeutics has been ranked #2 over 28 related journals in the Medical Laboratory Technology research category. The ranking percentile of Diabetes Technology and Therapeutics is around 94% in the field of Medical Laboratory Technology.
· In the Endocrinology, Diabetes and Metabolism research field, the Quartile of Diabetes Technology and Therapeutics is Q1. Diabetes Technology and Therapeutics has been ranked #26 over 217 related journals in the Endocrinology, Diabetes and Metabolism research category. The ranking percentile of Diabetes Technology and Therapeutics is around 88% in the field of Endocrinology, Diabetes and Metabolism.
· In the Endocrinology research field, the Quartile of Diabetes Technology and Therapeutics is Q1. Diabetes Technology and Therapeutics has been ranked #17 over 118 related journals in the Endocrinology research category. The ranking percentile of Diabetes Technology and Therapeutics is around 86% in the field of Endocrinology.

Diabetes Technology and Therapeutics Impact Factor 2020-2021 Prediction

Diabetes Technology and Therapeutics Impact Factor Predition System

Diabetes Technology and Therapeutics Impact Factor Prediction System is now online. You can start share your valuable insights with the community.

Predict Check All Preditions
Total Publications
2869
Total Citations
76344

Annual Publication Volume

Annual Citation Record

International Collaboration Trend

Cited Documents Trend

Journal Impact IF History

Year Journal Impact IF
Year Journal Impact IF
2019-2020 4.403
2018-2019 4.488
2017-2018 2.921
2016-2017 2.698
2015-2016 2.198
2014-2015 2.106
2013-2014 2.293
2012-2013 2.205
2011-2012 1.931
Journal Impact IF History

· The 2019-2020 Journal Impact IF of Diabetes Technology and Therapeutics is 4.403
· The 2018-2019 Journal Impact IF of Diabetes Technology and Therapeutics is 4.488
· The 2017-2018 Journal Impact IF of Diabetes Technology and Therapeutics is 2.921
· The 2016-2017 Journal Impact IF of Diabetes Technology and Therapeutics is 2.698
· The 2015-2016 Journal Impact IF of Diabetes Technology and Therapeutics is 2.198
· The 2014-2015 Journal Impact IF of Diabetes Technology and Therapeutics is 2.106
· The 2013-2014 Journal Impact IF of Diabetes Technology and Therapeutics is 2.293
· The 2012-2013 Journal Impact IF of Diabetes Technology and Therapeutics is 2.205
· The 2011-2012 Journal Impact IF of Diabetes Technology and Therapeutics is 1.931

Publications Cites Dataset

Year Publications Citations
Year Publications Citations
1999 62 64
2000 87 109
2001 62 179
2002 83 495
2003 84 802
2004 99 1195
2005 119 1456
2006 80 2222
2007 76 2593
2008 76 2936
2009 142 3520
2010 155 3750
2011 175 4125
2012 201 5126
2013 217 5581
2014 178 5770
2015 186 5895
2016 182 5768
2017 141 5985
2018 134 5473
2019 127 5592
2020 187 7167
2021 16 541
Publications Cites Dataset

· The Diabetes Technology and Therapeutics has published 62 reports and received 64 citations in 1999.
· The Diabetes Technology and Therapeutics has published 87 reports and received 109 citations in 2000.
· The Diabetes Technology and Therapeutics has published 62 reports and received 179 citations in 2001.
· The Diabetes Technology and Therapeutics has published 83 reports and received 495 citations in 2002.
· The Diabetes Technology and Therapeutics has published 84 reports and received 802 citations in 2003.
· The Diabetes Technology and Therapeutics has published 99 reports and received 1195 citations in 2004.
· The Diabetes Technology and Therapeutics has published 119 reports and received 1456 citations in 2005.
· The Diabetes Technology and Therapeutics has published 80 reports and received 2222 citations in 2006.
· The Diabetes Technology and Therapeutics has published 76 reports and received 2593 citations in 2007.
· The Diabetes Technology and Therapeutics has published 76 reports and received 2936 citations in 2008.
· The Diabetes Technology and Therapeutics has published 142 reports and received 3520 citations in 2009.
· The Diabetes Technology and Therapeutics has published 155 reports and received 3750 citations in 2010.
· The Diabetes Technology and Therapeutics has published 175 reports and received 4125 citations in 2011.
· The Diabetes Technology and Therapeutics has published 201 reports and received 5126 citations in 2012.
· The Diabetes Technology and Therapeutics has published 217 reports and received 5581 citations in 2013.
· The Diabetes Technology and Therapeutics has published 178 reports and received 5770 citations in 2014.
· The Diabetes Technology and Therapeutics has published 186 reports and received 5895 citations in 2015.
· The Diabetes Technology and Therapeutics has published 182 reports and received 5768 citations in 2016.
· The Diabetes Technology and Therapeutics has published 141 reports and received 5985 citations in 2017.
· The Diabetes Technology and Therapeutics has published 134 reports and received 5473 citations in 2018.
· The Diabetes Technology and Therapeutics has published 127 reports and received 5592 citations in 2019.
· The Diabetes Technology and Therapeutics has published 187 reports and received 7167 citations in 2020.
· The Diabetes Technology and Therapeutics has published 16 reports and received 541 citations in 2021.
· The total publications of Diabetes Technology and Therapeutics is 2869.
· The total citations of Diabetes Technology and Therapeutics is 76344.

What is Impact Factor?

The impact factor (IF) or journal impact factor (JIF) of an academic journal is a scientometric index calculated by Clarivate that reflects the yearly average number of citations of articles published in the last two years in a given journal. It is frequently used as a proxy for the relative importance of a journal within its field; journals with higher impact factor values are often deemed to be more important, or carry more intrinsic prestige in their respective fields, than those with lower values.

Diabetes Technology and Therapeutics | Academic Accelerator - About the Impact Factor

Impact factor is commonly used to evaluate the relative importance of a journal within its field and to measure the frequency with which the “average article” in a journal has been cited in a particular time period. Journal which publishes more review articles will get highest IFs. Journals with higher IFs believed to be more important than those with lower ones. According to Eugene Garfield “impact simply reflects the ability of the journals and editors to attract the best paper available.” Journal which publishes more review articles will get maximum IFs. The Impact Factor of an academic journal is a scientometric Metric that reflects the yearly average number of citations that recent articles published in a given journal received. It is frequently used as a Metric for the relative importance of a journal within its field; journals with higher Impact Factor are often deemed to be more important than those with lower ones. The Diabetes Technology and Therapeutics Impact Factor IF measures the average number of citations received in a particular year (2020) by papers published in the Diabetes Technology and Therapeutics during the two preceding years (2018-2019). Note that 2020 Impact Factor are reported in 2021; they cannot be calculated until all of the 2020 publications have been processed by the indexing agency. New journals, which are indexed from their first published issue, will receive an impact factor after two years of indexing; in this case, the citations to the year prior to Volume 1, and the number of articles published in the year prior to Volume 1, are known zero values. Journals that are indexed starting with a volume other than the first volume will not get an impact factor until they have been indexed for three years. Occasionally, Journal Citation Reports assigns an impact factor to new journals with less than two years of indexing, based on partial citation data. The calculation always uses two complete and known years of item counts, but for new titles one of the known counts is zero. Annuals and other irregular publications sometimes publish no items in a particular year, affecting the count. The impact factor relates to a specific time period; it is possible to calculate it for any desired period. In addition to the 2-year Impact Factor, the 3-year Impact Factor, 4-year Impact Factor, 5-year Impact Factor, Real-Time Impact Factor can provide further insights and factors into the impact of Diabetes Technology and Therapeutics.

History

The impact factor was devised by Eugene Garfield, the founder of the Institute for Scientific Information (ISI). Impact factors are calculated yearly starting from 1975 for journals listed in the Journal Citation Reports (JCR). ISI was acquired by Thomson Scientific & Healthcare in 1992, and became known as Thomson ISI. In 2018, Thomson ISI was sold to Onex Corporation and Baring Private Equity Asia. They founded a new corporation, Clarivate, which is now the publisher of the JCR.

Use

The impact factor is used to compare different journals within a certain field. The Web of Science indexes more than 11,500 science and social science journals. Journal impact factors are often used to evaluate the merit of individual articles and individual researchers. This use of impact factors was summarised by Hoeffel:

Impact Factor is not a perfect tool to measure the quality of articles but there is nothing better and it has the advantage of already being in existence and is, therefore, a good technique for scientific evaluation. Experience has shown that in each specialty the best journals are those in which it is most difficult to have an article accepted, and these are the journals that have a high impact factor. Most of these journals existed long before the impact factor was devised. The use of impact factor as a measure of quality is widespread because it fits well with the opinion we have in each field of the best journals in our specialty....In conclusion, prestigious journals publish papers of high level. Therefore, their impact factor is high, and not the contrary.

Eugene Garfield

In brief, Impact factors may be used by:
  • Authors to decide where to submit an article for publication.
  • Libraries to make collection development decisions
  • Academic departments to assess academic productivity
  • Academic departments to make decisions on promotion and tenure.
As impact factors are a journal-level metric, rather than an article- or individual-level metric, this use is controversial. Garfield agrees with Hoeffel,but warns about the "misuse in evaluating individuals" because there is "a wide variation [of citations] from article to article within a single journal". Other things to consider about Impact Factors:
  • Many journals do not have an impact factor.
  • The impact factor cannot assess the quality of individual articles. Even if citations were evenly distributed among articles, the impact factor would only measure the interests of other researchers in an article, not its importance and usefulness.
  • Only research articles, technical notes and reviews are “citable” items. Editorials, letters, news items and meeting abstracts are “non-citable items”.
  • Only a small percentage of articles are highly cited and they are found in a small subset of journals. This small proportion accounts for a large percentage of citations.
  • Controversial papers, such as those based on fraudulent data, may be highly cited, distorting the impact factor of a journal.
  • Citation bias may exist. For example, English language resources may be favoured. Authors may cite their own work.
Moreover, informed and careful use of these impact data is essential, and should be based on a thorough understanding of the methodology used to generate impact factors. There are controversial aspects of using impact factors:
  • It is not clear whether the number of times a paper is cited measures its actual quality.
  • Some databases that calculate impact factors fail to incorporate publications including textbooks, handbooks and reference books.
  • Certain disciplines have low numbers of journals and usage. Therefore, one should only compare journals or researchers within the same discipline.
  • Review articles normally are cited more often and therefore can skew results.
  • Self-citing may also skew results.
  • Some resources used to calculate impact factors have inadequate international coverage.
  • Editorial policies can artificially inflate an impact factor.
Impact factors have often been used in advancement and tenure decision-making. Many recognize that this is a coarse tool for such important decisions, and that a multitude of factors should be taken into account in these deliberations. When considering the use of the impact factor (IF), keep these aspects in mind:
  • IF analysis is limited to citations from the journals indexed by the Web of Science/Web of Knowledge. Currently, the Web of Science indexes only 8621 journals across the full breadth of the sciences, and just 3121 in the social sciences.
  • A high IF/citation rate says nothing about the quality -- or even, validity -- of the references being cited. Notorious or even retracted articles often attract a lot of attention, hence a high number of citations. The notority related to the first publication on "cold fusion" is one such example.
  • Journals that publish more "review articles" are often found near the top of the rankings. While not known for publishing new, creative findings, these individual articles tend to be heavily cited.
  • The IF measures the average number of citations to articles in the journal -- given this, a small number of highly-cited articles will skew the figure.
  • It takes several years for new journals to be added to the list of titles indexed by the Web of Science/Web of Knowledge, so these newer titles will be under-represented.
  • It's alleged that journal editors have learned to "game" the system, encouraging authors to cite their works previously published in the same journal.
Comparing Journals Across Disciplines? Not a good idea! Using Impact Factors within a given discipline should only be done with great care, as described above. Using impact factor data to compare journals across disciplines is even more problematic. Here are some of the reasons:
  • Disciplines where older literature is still referenced, such as Chemistry and Mathematics, offer challenges to the methodolgy since older citations (older than two years) are not used to calculate the impact factor for a given journal. (Five-year impact factor analysis, which can be calculated using the Journal Citation Index database, helps smooth out this problem only to some degree.)
  • Different disciplines have different practices regarding tendency to cite larger numbers of references. Higher overall citation rates will bump upward impact factor measurements.
  • Where it's common for large numbers of authors to collaborate on a single paper, such as in Physics, the tendency of authors to cite themselves (and in this case, more authors) will result in increased citation rates.

Pros and Cons of the Impact Factor

Pros:

  • A vetted, established metric for measuring journal impact within a discipline.
  • Designed to eliminate bias based on journal size and frequency.
Cons:
  • Individual articles makes an uneven contribution to overall Impact Factor.
  • Impact Factor does not account for certain things, things like context (postive or negative citaion) and intentionality (self-citation).
  • The metric is proprietary to and bound by the contents of the Thomson Reuters database.
  • Citations, on which the Impact Factor is based, count for less than 1% of an article's overall use.

Criticism

Numerous critiques have been made regarding the use of impact factors. A 2007 study noted that the most fundamental flaw is that impact factors present the mean of data that are not normally distributed, and suggested that it would be more appropriate to present the median of these data. There is also a more general debate on the validity of the impact factor as a measure of journal importance and the effect of policies that editors may adopt to boost their impact factor (perhaps to the detriment of readers and writers). Other criticism focuses on the effect of the impact factor on behavior of scholars, editors and other stakeholders. Others have made more general criticisms, arguing that emphasis on impact factor results from negative influence of neoliberal policies on academia claiming that what is needed is not just replacement of the impact factor with more sophisticated metrics for science publications but also discussion on the social value of research assessment and the growing precariousness of scientific careers in higher education.
Experts stress that there are limitations in using impact factors to evaluate a scholar's work. There are many reasons cited for not relying on impact factor alone to evaluate the output of a particular individual. Among these are the following:

  • A single factor is not sufficient for evaluating an author's work.
  • Journal values are meaningless unless compared within the same discipline. Impact factors vary among disciplines.
  • The impact factor was originally devised to show the impact of a specific journal, not a specific scholar. The quality and impact of the author's work may extend beyond the impact of a particular journal.
According to Jim Testa, a researcher for ThomsonReuters Scientific, the most widespread misuse of the Impact Factor is to evaluate the work of an individual author (instead of a journal). "To say that because a researcher is publishing in a certain journal, he or she is more influential or deserves more credit is not necessarily true. There are many other variables to consider." (interview 6/26/2008 in Thomson Reuters blog entry)

Diabetes Technology and Therapeutics
Journal Profile

About

Diabetes Technology & Therapeutics is the only peer-reviewed journal providing healthcare professionals with information on new devices, drugs, drug delivery systems, and software for managing patients with diabetes. This leading international journal delivers practical information and comprehensive coverage of cutting-edge technologies and therapeutics in the field, and each issue highlights new pharmacological and device developments to optimize patient care. None

Highly Cited Keywords

ISSN
1520-9156
ISSN

The ISSN of Diabetes Technology and Therapeutics is 1520-9156 . An ISSN is an 8-digit code used to identify newspapers, journals, magazines and periodicals of all kinds and on all media–print and electronic.

ISSN (Online)
1557-8593
ISSN (Online)

The ISSN (Online) of Diabetes Technology and Therapeutics is 1557-8593 . An ISSN is an 8-digit code used to identify newspapers, journals, magazines and periodicals of all kinds and on all media–print and electronic.

Publisher
Mary Ann Liebert Inc.
Publisher

Diabetes Technology and Therapeutics is published by Mary Ann Liebert Inc. .

Publication Frequency
Bimonthly
Publication Frequency

Diabetes Technology and Therapeutics publishes reports Bimonthly .

Coverage
1999 - Present
Coverage

The Publication History of Diabetes Technology and Therapeutics covers 1999 - Present .

Open Access
NO
Open Access

Diabetes Technology and Therapeutics is Subscription-based (non-OA) Journal. Publishers own the rights to the articles in their journals. Anyone who wants to read the articles should pay by individual or institution to access the articles. Anyone who wants to use the articles in any way must obtain permission from the publishers.

Publication Fee
Publication Fee

There is no publication fee for submiting manuscript to Diabetes Technology and Therapeutics. Diabetes Technology and Therapeutics is Subscription-based (non-OA) Journal. Publishers own the rights to the articles in their journals. Anyone who wants to read the articles should pay by individual or institution to access the articles.

Language
English
Language

The language of Diabetes Technology and Therapeutics is English .

Country/Region
United States
Country/Region

The publisher of Diabetes Technology and Therapeutics is Mary Ann Liebert Inc. , which locates in United States .

Selected Articles

Full Title Authors
Full Title Authors
Preserving Skin Integrity with Chronic Device Use in Diabetes B WelshJohn · B WelshJohn
How Should We Assess Glycemic Variability in Type 1 Diabetes? Contribution of Principal Component Analysis for Interstitial Glucose Indices in 142 Children H MesserLaurel · H MesserLaurel
Advances in Care for Insulin-Requiring Patients Without Closed Loop S BaileyTimothy · WalshJohn · Y StoneJenine · Y StoneJenine
Emerging Technologies for Diabetes Care N ShahViral · M LaffelLori · WadwaR. Paul · K GargSatish · K GargSatish
Clinical Implications of Lipohypertrophy Among People with Type 1 Diabetes in India YuShengsheng · VarugheseBiju · LiZhiyi · R KushnerPam · R KushnerPam
10th Annual Symposium on Self-Monitoring of Blood Glucose, April 27–29, 2017, Warsaw, Poland HeinemannLutz · W CarterAlan · W CarterAlan
A Qualitative Analysis of Real-Time Continuous Glucose Monitoring Data Sharing with Care Partners: To Share or Not to Share? BurnerElizabeth · LamChun Nok · DeRossRebecca · Kagawa-SingerMarjorie · MenchineMichael · AroraSanjay · AroraSanjay
Using Mobile Health to Improve Social Support for Low-Income Latino Patients with Diabetes: A Mixed-Methods Analysis of the Feasibility Trial of TExT-MED + FANS SzadkowskaAgnieszka · GawreckiAndrzej · MichalakArkadiusz · Zozulińska-ZiółkiewiczDorota · FendlerWojciech · MłynarskiWojciech · MłynarskiWojciech
Flash Glucose Measurements in Children with Type 1 Diabetes in Real-Life Settings: To Trust or Not to Trust? GarciaArturo · K BaloAndrew · A BuckinghamBruce · B HirschIrl · A PeyserThomas · A PeyserThomas
Flash Glucose Monitoring in Younger Individuals with Diabetes: Accuracy and Patient Experience in Real-World Settings A PeyserThomas · K BaloAndrew · A BuckinghamBruce · B HirschIrl · GarciaArturo · GarciaArturo
Glycemic Variability Percentage: A Novel Method for Assessing Glycemic Variability from Continuous Glucose Monitor Data ChlupRudolf · RunzisSarah · CastanedaJavier · W LeeScott · NguyenXuan · CohenOhad · CohenOhad
Toward Calibration-Free Continuous Glucose Monitoring Sensors: Bayesian Calibration Approach Applied to Next-Generation Dexcom Technology L LevittDavid · K SpanakisElias · A RyanKathleen · D SilverKristi · D SilverKristi
Insulin Pump and Continuous Glucose Monitor Initiation in Hospitalized Patients with Type 2 Diabetes Mellitus MaiorinoMaria Ida · BellastellaGiuseppe · CascianoOfelia · CirilloPaolo · SimeonVittorio · ChiodiniPaolo · PetrizzoMichela · GicchinoMaurizio · RomanoOrnella · CarusoPaola · GiuglianoDario · EspositoKatherine · EspositoKatherine
Glucose Variability: A Review of Clinical Applications and Research Developments AkturkHalis Kaan · RewersAmanda · JosephHal · SchneiderNicole · K GargSatish · K GargSatish
Recommendations for Initiating Use of Afrezza Inhaled Insulin in Individuals with Type 1 Diabetes K GargSatish · AkturkH. Kaan · AkturkH. Kaan
Beyond HbA1c: Comparing Glycemic Variability and Glycemic Indices in Predicting Hypoglycemia in Type 1 and Type 2 Diabetes Rama ChandranSuresh · TayWei Lin · LyeWeng Kit · LimLee Ling · RatnasingamJeyakantha · TanAlexander Tong Boon · S L GardnerDaphne · S L GardnerDaphne
COMPARISON OF CLINICAL CHARACTERISTICS OF A DIABETES TELEHEALTH SERVICE WITH SPECIALIST FACE-TO-FACE OUTPATIENTS: A CROSS-SECTIONAL SURVEY Anish Menon · Darsy Darssan · Farhad Fatehi · Dominique Bird · Anthony W. Russell · Leonard C. Gray · Leonard C. Gray
Telemedicine Cost–Effectiveness for Diabetes Management: A Systematic Review LeeJun Yang · LeeShaun Wen Huey · LeeShaun Wen Huey
Hypoglycemia: New Definitions and Regulatory Implications PicardSylvie · HanaireHélène · ReznikYves · BenhamouPierre-Yves · FendriSalha · DufaitreLise · LeuteneggerEric · GuerciBruno · GuerciBruno
Ever-Increasing Insulin-Requiring Patients Globally W RodbardHelena · W RodbardHelena
Mobile Momentary Assessment and Biobehavioral Feedback for Adolescents with Type 1 Diabetes: Feasibility and Engagement Patterns WadwaR. Paul · M LaffelLori · N ShahViral · K GargSatish · K GargSatish
Accuracy of a Factory-Calibrated, Real-Time Continuous Glucose Monitoring System During 10 Days of Use in Youth and Adults with Diabetes BergAnna Korsgaard · BergAnna Korsgaard · NørgaardKirsten · NørgaardKirsten · P ThyssenJacob · ZachariaeClaus · HommelEva · RytterKaren · SvenssonJannet · SvenssonJannet · SvenssonJannet
Skin Problems Associated with Insulin Pumps and Sensors in Adults with Type 1 Diabetes: A Cross-Sectional Study PettusJeremy · Santos CavaiolaTricia · V EdelmanSteven · V EdelmanSteven
Design and Clinical Evaluation of a Novel Low-Glucose Prediction Algorithm with Mini-Dose Stable Glucagon Delivery in Post-Bariatric Hypoglycemia SchiavonMichele · Dalla ManChiara · CobelliClaudio · CobelliClaudio
CoYoT1 Clinic: Home Telemedicine Increases Young Adult Engagement in Diabetes Care W ReidMark · KrishnanSubramanian · BergetCari · CainCindy · ThomasJohn “Fred” · J KlingensmithGeorgeanna · K RaymondJennifer · K RaymondJennifer
Continuous Glucose Monitoring in Healthy Children Aged 2–8 Years Christopher G. Parkin · Anita Homberg · Rolf Hinzmann · Rolf Hinzmann
DTT: 20 Years and Counting … PolskySarit · PolskySarit
The Effectiveness of Continuous Glucose Monitoring in Patients with Type 2 Diabetes: A Systematic Review of Literature and Meta-analysis TorimotoKeiichi · OkadaYosuke · HajimeMaiko · TanakaKenichi · TanakaYoshiya · TanakaYoshiya
The Accuracy of Point-of-Care Equipment for Glucose Measurement in Screening for Dysglycemia in Patients with Coronary Artery Disease ParkCindy · A LeQuang · A LeQuang
Response to Yu et al. ArticleHealthcare Resource Waste Associated with Patient Nonadherence and Early Discontinuation of Traditional Continuous Glucose Monitoring in Real-World Settings: A Multicountry Analysis ShahimBahira · KjellströmBarbro · GybergViveca · JenningsCatriona · SmetanaStina · RydénLars · RydénLars
Disparities in the Efficacy of Metformin in Combination with Dipeptidyl Peptidase-4 Inhibitor as Initial Treatment Stratified by Dosage and Ethnicity: A Meta-Analysis G ParkinChristopher · G ParkinChristopher
Prediction Quality of Glucose Trend Indicators in Two Continuous Tissue Glucose Monitoring SystemsParts of these data were previously presented at the 53rd Annual Meeting of the European Association for the Study of Diabetes, September 11–15, 2017, Lisbon, Portugal Takeshi Osonoi · Maki Gouda · Mamiko Kubo · Kenji Arakawa · Toshio Hashimoto · Masanori Abe · Masanori Abe
Effects of Insulin Treatment with Glargine or Premixed Insulin Lispro Programs in Type 2 Diabetes Mellitus Patients: A Meta-analysis of Randomized Clinical Trials Guido Freckmann · Manuela Link · Antje Westhoff · Ulrike Kamecke · Stefan Pleus · Cornelia Haug · Cornelia Haug
The Effect of Reduced Self-Monitored Blood Glucose Testing After Adoption of Continuous Glucose Monitoring on Hemoglobin A1c and Time in RangeData reported previously in Price, DA, et al. (2017). Glycemic impact of reduced frequency of blood glucose monitoring with continuous glucose monitoring use. Diabetes 66(S1):A239 SunDi · ZhangXu · HouXiu-xin · HouXiu-xin
Perception and Possible Causes of Skin Problems to Insulin Pump and Glucose Sensor: Results from Pediatric Focus Groups PuhrSarah · CalhounPeter · B WelshJohn · C WalkerTomas · C WalkerTomas
Baseline Glycated Hemoglobin Values Predict the Magnitude of Glycemic Improvement in Patients with Type 1 and Type 2 Diabetes: Subgroup Analyses from the DIAMOND Study Program BergAnna Korsgaard · BergAnna Korsgaard · SimonsenAnne Birgitte · SvenssonJannet · SvenssonJannet · SvenssonJannet
Sustained Continuous Glucose Monitor Use in Low-Income Youth with Type 1 Diabetes Following Insurance Coverage Supports Expansion of Continuous Glucose Monitor Coverage for All Liana K. Billings · Liana K. Billings · Christopher G. Parkin · David A. Price · David A. Price
Continuous Glucose Monitoring and Insulin Informed Advisory System with Automated Titration and Dosing of Insulin Reduces Glucose Variability in Type 1 Diabetes Mellitus Priya Prahalad · Ananta Addala · Bruce Buckingham · Darrell M. Wilson · David M. Maahs · David M. Maahs
Optimal Sampling Duration for Continuous Glucose Monitoring to Determine Long-Term Glycemic Control D BretonMarc · D PatekStephen · LvDayu · SchertzElaine · RobicJessica · PinnataJennifer · KollarLaura · BarnettCharlotte · WakemanChristian · OliveriMary · FabrisChiara · ChernavvskyDaniel · P KovatchevBoris · M AndersonStacey · M AndersonStacey
Effect of Insulin Analogs on Frequency of Non-Severe Hypoglycemia in Patients with Type 1 Diabetes Prone to Severe Hypoglycemia: Much Higher Rates Detected by Continuous Glucose Monitoring than by Self-Monitoring of Blood Glucose - The HypoAna Trial RiglaMercedes · PonsBelén · RebasaPere · LunaAlexis · PozoFrancisco Javier · CaixàsAssumpta · VillaplanaMaria · SubíasDavid · BellaMaria Rosa · CombaliaNeus · CombaliaNeus
Ongoing Debate About Models for Artificial Pancreas Systems and In Silico Studies MoscardóVanessa · BondiaJorge · J Ampudia-BlascoFrancisco · G FanelliCarmine · LucidiPaola · RossettiPaolo · RossettiPaolo
Accuracy of a Fourth-Generation Continuous Glucose Monitoring System in Children and Adolescents with Type 1 Diabetes Ryo Shibusawa · Eijiro Yamada · Shuichi Okada · Yasuyo Nakajima · Claire C. Bastie · Masanobu Yamada · Masanobu Yamada
The Impact of Short-Term Professional Continuous Glucose Monitoring on Glycemic Control Via Lifestyle Improvement K GargSatish · L PetersAnne · B BuseJohn · DanneThomas · DanneThomas
Defining Glycemic Variability in Very Low-Birthweight Infants: Data from a Continuous Glucose Monitoring System Pilar Isabel Beato-Víbora · Carmen Quirós-López · Lucía Lázaro-Martín · María Martín-Frías · Raquel Barrio-Castellanos · Estela Gil-Poch · Francisco Javier Arroyo-Díez · Marga Giménez-Álvarez · Marga Giménez-Álvarez
11th Annual Symposium on Self-Monitoring of Blood Glucose: April 12–14, 2018, Oslo, Norway Harold W. de Valk · Sandrine Lablanche · Emanuele Bosi · Pratik Choudhary · Julien Da Silva · Javier Castaneda · Linda Vorrink · Simona de Portu · Ohad Cohen · Ohad Cohen
Continuous Subcutaneous Insulin Infusion Can Be Used Effectively and Safely in Older Patients with Type 1 Diabetes: Long-Term Follow-up Christopher G. Parkin · Anita Homberg · Rolf Hinzmann · Rolf Hinzmann
Excellent Glycemic Control Maintained by Open-Source Hybrid Closed-Loop AndroidAPS During and After Sustained Physical Activity M BrigantiEsther · C SummersJulia · A FitzgeraldZachary · N J LambersLeo · D CohenNeale · D CohenNeale
Effectiveness of Digital Interventions for Improving Glycemic Control in Persons with Poorly Controlled Type 2 Diabetes: A Systematic Review, Meta-analysis, and Meta-regression Analysis Lenka Petruzelkova · Jan Šoupal · Veronika Plasova · Pavlina Jiranova · Vit Neuman · Lukas Plachy · Stepanka Pruhova · Zdenek Sumnik · Barbora Obermannova · Barbora Obermannova
Switching from Flash Glucose Monitoring to Continuous Glucose Monitoring on Hypoglycemia in Adults with Type 1 Diabetes at High Hypoglycemia Risk: The Extension Phase of the I HART CGM Study M KebedeMihiretu · M KebedeMihiretu · M KebedeMihiretu · ZeebHajo · ZeebHajo · PetersManuela · PetersManuela · L HeiseThomas · L HeiseThomas · PischkeClaudia R · PischkeClaudia R · PischkeClaudia R
Impact of Sensor-Augmented Pump Therapy with Predictive Low-Glucose Suspend Function on Glycemic Control and Patient Satisfaction in Adults and Children with Type 1 Diabetes Monika Reddy · Narvada Jugnee · Sinthuka Anantharaja · Nick Oliver · Nick Oliver
Performance of Medtronic Hybrid Closed-Loop Iterations: Results from a Randomized Trial in Adolescents with Type 1 Diabetes JagłaMateusz · SzymońskaIzabela · StarzecKatarzyna · GachOlga · WłodarczykAneta · KwintaPrzemko · KwintaPrzemko
Retrospective Analysis of 3-Month Real-World Glucose Data After the MiniMed 670G System Commercial Launch SugiyamaYuki · WakabayashiRyo · UrasawaMasatoshi · MaruyamaYuki · ShimizuSari · KawamataMikito · KawamataMikito
Improved Postprandial Glucose with Inhaled Technosphere Insulin Compared with Insulin Aspart in Patients with Type 1 Diabetes on Multiple Daily Injections: The STAT Study de BockMartin · de BockMartin · DartJulie · HancockMichael · SmithGrant · A DavisElizabeth · A DavisElizabeth · W JonesTimothy · W JonesTimothy · W JonesTimothy
Development of a Collaborative Algorithm for the Management of Type 2 Diabetes during Ramadan: An Anchor on Empowerment AkturkHalis Kaan · K Snell-BergeonJanet · RewersAmanda · J KlaffLeslie · W BodeBruce · L PetersAnne · S BaileyTimothy · K GargSatish · K GargSatish
Multivariable Artificial Pancreas for Various Exercise Types and Intensities LumZheng Kang · See TohWei Yann · See TohWei Yann · LimSze Mian · RusliKhairul Dzakirin Bin · Abdul ShakoorShaikh Abdul Kader Kamaldeen · TsouKeith Yu Kei · ChewDaniel Ek Kwang · DalanRinkoo · KwekSing Cheer · OthmanNoorani · LianJoyce Xia · LeeJoyce Yu-Chia · LeeJoyce Yu-Chia · LeeJoyce Yu-Chia
Psychosocial and Human Factors During a Trial of a Hybrid Closed Loop System for Type 1 Diabetes Management TurksoyKamuran · HajizadehIman · HobbsNicole · KilkusJennifer · LittlejohnElizabeth · LittlejohnElizabeth · SamadiSediqeh · FengJianyuan · SevilMert · LazaroCaterina · RitthalerJulia · HibnerBrooks · DevineNancy · QuinnLaurie · CinarAli · CinarAli
A Slow-Digesting, Low-Glycemic Load Nutritional Beverage Improves Glucose Tolerance in Obese Pregnant Women Without Gestational Diabetes Jicheng Yu · Yuqi Zhang · Yanqi Ye · Rocco DiSanto · Wujin Sun · Davis Ranson · Frances S. Ligler · John B. Buse · Zhen Gu · Zhen Gu
Perioperative Characteristics of the Accuracy of Subcutaneous Continuous Glucose Monitoring: Pilot Study in Neurosurgery and Cardiac Surgery R HenryRobert · StrangePoul · ZhouRong · PettusJeremy · ShiLeon · B ZhuplatovSergey · MansfieldTraci · KleinDavid · KatzArie · KatzArie
Is It Safe to UseOn-DemandContinuous Glucose Monitoring During Pregnancy? Gregory P. Forlenza · Gregory P. Forlenza
Effect of Canagliflozin on Urinary Albumin Excretion in Japanese Patients with Type 2 Diabetes Mellitus and Microalbuminuria: A Pilot Study CaiXiaoling · GaoXueying · YangWenjia · JiLinong · JiLinong
Optimizing the Estimation of Carbohydrate-to-Insulin Ratio and Correction Factor BattelinoTadej · BattelinoTadej · W BodeBruce · W BodeBruce
Immune Intervention for Type 1 Diabetes HoshinaSari · S AndersenGregers · E JørgensenMarit · E JørgensenMarit · RidderstråleMartin · RidderstråleMartin · VistisenDorte · U AndersenHenrik · U AndersenHenrik
A Prospective Multicenter Evaluation of the Accuracy of a Novel Implanted Continuous Glucose Sensor: PRECISE II SamadiSediqeh · RashidMudassir · TurksoyKamuran · FengJianyuan · HajizadehIman · HobbsNicole · LazaroCaterina · SevilMert · LittlejohnElizabeth · CinarAli · CinarAli
Continuous Glucose Monitoring in 2017 P ChristiansenMark · J KlaffLeslie · BrazgRon · R ChangAnna · J LevyCarol · LamDavid · S DenhamDouglas · AtieeGeorge · W BodeBruce · J WaltersSteven · KelleyLynne · S BaileyTimothy · S BaileyTimothy
Treatment Modality–Dependent Risk of Diabetic Ketoacidosis in Patients with Type 1 Diabetes: Danish Adult Diabetes Database Study Eleanor M. Scott · Rudy Bilous · Alexandra Kautzky-Willer · Alexandra Kautzky-Willer
Automatic Detection and Estimation of Unannounced Meals for Multivariable Artificial Pancreas System B HirschIrl · B HirschIrl
Can Biomarkers Help Target Maturity-Onset Diabetes of the Young Genetic Testing in Antibody-Negative Diabetes? AbitbolAlexander · Rabasa-LhoretRémi · MessierVirginie · LegaultLaurent · SmaouiMohamad · CohenNathan · HaidarAhmad · HaidarAhmad · HaidarAhmad
Overnight Glucose Control with Dual- and Single-Hormone Artificial Pancreas in Type 1 Diabetes with Hypoglycemia Unawareness: A Randomized Controlled Trial M Schiavon · R Visentin · C. Dalla Man · T Klabunde · C. Cobelli · C. Cobelli
Healthcare Resource Waste Associated with Patient Nonadherence and Early Discontinuation of Traditional Continuous Glucose Monitoring in Real-World Settings: A Multicountry Analysis RodbardDavid · RodbardDavid
Possible Ways to Improve Postprandial Glucose Control in Type 1 Diabetes DanneThomas · BiesterTorben · KordonouriOlga · KordonouriOlga
Combined SGLT1 and SGLT2 Inhibitors and Their Role in Diabetes Care Anna-Lena Brorsson · A. Lindholm Olinder · Janeth Leksell · Gunnel Viklund · Gunnel Viklund
Evaluation of an Artificial Pancreas with Enhanced Model Predictive Control and a Glucose Prediction Trust Index with Unannounced Exercise BonatoLisa · TalebNadine · GingrasVéronique · MessierVirginie · GobeilFernand · GobeilFernand · MénardJulie · ArdilouzeJean-Luc · ArdilouzeJean-Luc · Rabasa-LhoretRémi · Rabasa-LhoretRémi
Duration of Catheter Use in Patients with Diabetes Using Continuous Subcutaneous Insulin Infusion: A Review A StewartZoe · A StewartZoe · M YamamotoJennifer · E WilinskaMalgorzata · HartnellSarah · FarringtonConor · HovorkaRoman · R MurphyHelen · R MurphyHelen · R MurphyHelen · R MurphyHelen
Adaptability of Closed Loop During Labor, Delivery, and Postpartum: A Secondary Analysis of Data from Two Randomized Crossover Trials in Type 1 Diabetes Pregnancy JendleJohan · HeinemannLutz · HeinemannLutz
The Effects of Subcutaneous Insulin Infusion Versus Multiple Insulin Injections on Glucose Variability in Young Adults with Type 1 Diabetes: The 2-Year Follow-Up of the Observational METRO Study GawreckiAndrzej · Zozulińska-ZiółkiewiczDorota · MatejkoBartłomiej · HohendorffJerzy · T MaleckiMaciej · KlupaTomasz · KlupaTomasz
Safe Completion of a Trail Running Ultramarathon by Four Men with Type 1 Diabetes UemuraFumi · OkadaYosuke · TorimotoKeiichi · TanakaYoshiya · TanakaYoshiya
Relation Between Hypoglycemia and Glycemic Variability in Type 2 Diabetes Patients with Insulin Therapy: A Study Based on Continuous Glucose Monitoring CobelliClaudio · FacchinettiAndrea · FacchinettiAndrea
Yet Another Glucose Variability Index: Time for a Paradigm Change? J Laguna SanzAlejandro · M MullaChristopher · M FowlerKristen · CloutierEmilie · B GoldfineAllison · NewswangerBrett · CumminsMartin · DeshpandeSunil · J PrestrelskiSteven · StrangePoul · ZisserHoward · DoyleFrancis J.Iii · DassauEyal · DassauEyal · PattiMary-Elizabeth · PattiMary-Elizabeth
Role of Continuous Glucose Monitoring in Insulin-Requiring Patients with Diabetes Guilmin-CréponSophie · CarelJean-Claude · CarelJean-Claude · SchroedtJulien · ScornetErwan · AlbertiCorinne · AlbertiCorinne · Tubiana-RufiNadia · Tubiana-RufiNadia
A New Era in Continuous Glucose Monitoring: Food and Drug Administration Creates a New Category of Factory-Calibrated Nonadjunctive, Interoperable Class II Medical Devices H MesserLaurel · BergetCari · BeatsonChristie · PolskySarit · P ForlenzaGregory · P ForlenzaGregory
Response to Letter to the Editor (DOI: 10.1089/dia.2018.0057) David Rodbard · David Rodbard
Corrections of Equations on Glycemic Variability and Quality of Glycemic Control Irina Gaynanova · Jacek Urbanek · Naresh M. Punjabi · Naresh M. Punjabi
Glycemic Control in Adult Type 1 Diabetes Patients with Insulin Glargine, Insulin Detemir, or Continuous Subcutaneous Insulin Infusion in Daily Practice RautiainenPäivi · TirkkonenHilkka · LaatikainenTiina · LaatikainenTiina · LaatikainenTiina
Metrics to Evaluate Quality of Glycemic Control: Comparison of Time in Target, Hypoglycemic, and Hyperglycemic Ranges withRisk Indices RodbardDavid · RodbardDavid
Engagement with a Text-Messaging Intervention Improves Adherence in Adolescents with Type 1 Diabetes: Brief Report ZhangShuodan · HamburgerEmily · KahandaSachini · LyttleMorgan · WilliamsRodayne · S JaserSarah · S JaserSarah
Evaluation of Four Blood Glucose Monitoring Systems for Self-Testing with Built-in Insulin Dose Advisor Based on ISO 15197:2013: System Accuracy and Hematocrit Influence JendrikeNina · BaumstarkAnnette · PleusStefan · LiebingChristina · BeerAlexandra · FlackeFrank · HaugCornelia · FreckmannGuido · FreckmannGuido
Baseline Psychosocial Characteristics Predict Frequency of Continuous Glucose Monitoring in Youth with Type 1 Diabetes E McGillDayna · K VolkeningLisa · A ButlerDeborah · R HarringtonKara · L KatzMichelle · M LaffelLori · M LaffelLori
Assessment of Mitigation Methods to Reduce the Risk of Hypoglycemia for Announced Exercise in a Uni-hormonal Artificial Pancreas BertachiArthur · BertachiArthur · BeneytoAleix · M RamkissoonCharrise · VehíJosep · VehíJosep
A Randomized Clinical Trial of the Effect of Continuous Glucose Monitoring on Nocturnal Hypoglycemia, Daytime Hypoglycemia, Glycemic Variability, and Hypoglycemia Confidence in Persons with Type 1 Diabetes Treated with Multiple Daily Insulin Injections (GOLD-3) F ÓlafsdóttirArndís · PolonskyWilliam · BolinderJan · B HirschIrl · DahlqvistSofia · WedelHans · NyströmThomas · WijkmanMagnus · SchwarczErik · HellmanJarl · HeiseTim · LindMarcus · LindMarcus
Glucose Sensing in the Subcutaneous Tissue: Attempting to Correlate the Immune Response with Continuous Glucose Monitoring Accuracy Jeffrey I. Joseph · Gabriella J. Eisler · David Diaz · Abdurizzagh Khalf · Channy Loeum · Marc C. Torjman · Marc C. Torjman
Web Support for Weight-Loss Interventions: PREDIRCAM2 Clinical Trial Baseline Characteristics and Preliminary Results Alcántara-AragónValeria · Rodrigo-CanoSusana · Lupianez-BarberoAscension · MartinezMaría José · MartinezCarmen · TapiaJosé · IniestaJosé Manuel · TenesSusana · UrgellEulalia · NavarroGemma · HernandoM. Elena · HernandoM. Elena · Merino-TorresJuan Francisco · de LeivaAlberto · de LeivaAlberto · GonzalezCintia · GonzalezCintia · GonzalezCintia
Interference Assessment of Various Endogenous and Exogenous Substances on the Performance of the Eversense Long-Term Implantable Continuous Glucose Monitoring System LorenzCarrie · SandovalWendolyn · MortellaroMark · MortellaroMark
Automated Insulin Delivery Systems: Hopes and Expectations of Family Members P GarzaKimberly · JedraszkoAneta · E G WeilLindsey · NaranjoDiana · D BarnardKatharine · M LaffelLori · K HoodKorey · Weissberg-BenchellJill · Weissberg-BenchellJill · Weissberg-BenchellJill
The Hybrid Closed-Loop System: Evolution and Practical Applications W WeaverKathryn · B HirschIrl · B HirschIrl
Lessons Learned from Implementing a New Testing/Educational Tool for Patients Using an Insulin PumpA part of this research was presented as a poster in WCTD 2017 (The 2nd World Congress on Clinical Trials in Diabetes, Berlin, Germany, November 2017) and ATTD 2018 (Vienna, Austria, February 2018) StechovaKaterina · VanisMiroslav · TuhackovaMartina · UrbaniecKrzysztof · KvapilMilan · KvapilMilan
Sensor-Augmented Pump-Based Customized Mathematical Model for Type 1 Diabetes Benyamin Grosman · Di Wu · Diana Miller · Louis Lintereur · Anirban Roy · Neha J. Parikh · Francine R. Kaufman · Francine R. Kaufman
Performance of a Factory-Calibrated Real-Time Continuous Glucose Monitoring System Utilizing an Automated Sensor Applicator S GuptaSunil · S GuptaKavita · S GatheSachin · BamrahParvinder · S GuptaShlok · S GuptaShlok
In-Clinic Evaluation of the MiniMed 670G SystemSuspend Before LowFeature in Children with Type 1 Diabetes PolskySarit · WuMengdi · W BodeBruce · N DuBoseStephanie · S GolandRobin · M MaahsDavid · C FosterNicole · L PetersAnne · J LevyCarol · N ShahViral · W BeckRoy · W BeckRoy
Why Expectations Will Determine the Future of Artificial Pancreas A LalRayhan · BuckinghamBruce · M MaahsDavid · M MaahsDavid
Real-Time Continuous Glucose Monitoring Usage in Pilots with Diabetes: An Option to Improve Safety Martina Vettoretti · Andrea Facchinetti · Giovanni Sparacino · Claudio Cobelli · Claudio Cobelli
The Type 1 Diabetes Patient Decision Model Reproduces the Glycemic Outcomes of the REPLACE-BG Trial AnjanaRanjit Mohan · KesavadevJothydev · NeetaDeshpande · TiwaskarMangesh · PradeepaRajendra · JebaraniSaravanan · ThangamaniSuresh · SastryNadiminty Ganapathi · Brijendra KumarSrivastava · RamuMuthu · GuptaPokal Prasanna Kumar · VigneshJayaprakash · ChandruSundramoorthy · KayalvizhiSengottuvel · JagdishPadoor Sethuraman · UthraSubash Chandra Bose · LovelenaMunawar · JyotiSah · Suguna PriyaSengodan · KannanAlagarsamy · MohanViswanathan · UnnikrishnanRanjit · UnnikrishnanRanjit
Insulin Sensitivity Index-Based Optimization of Insulin to Carbohydrate Ratio: In Silico Study Shows Efficacious Protection Against Hypoglycemic Events Caused by Suboptimal Therapy SundbergFrida · SundbergFrida · ForsanderGun · ForsanderGun · ForsanderGun
Fully Closed-Loop Multiple Model Probabilistic Predictive Controller Artificial Pancreas Performance in Adolescents and Adults in a Supervised Hotel Setting P ForlenzaGregory · M CameronFaye · T LyTrang · LamDavid · P HowsmonDaniel · BaysalNihat · KulinaGeorgia · MesserLaurel · ClintonPaula · LevisterCamilla · D PatekStephen · J LevyCarol · WadwaR. Paul · M MaahsDavid · BequetteB. Wayne · A BuckinghamBruce · A BuckinghamBruce
Optimization of Insulin Regimen and Glucose Outcomes with Short-Term Real-Time Continuous Glucose Monitoring in Adult Type 1 Diabetes Patients with Suboptimal Control on Multiple Daily Injections: The Adult DIACCOR Study K GargSatish · H RewersAmanda · AkturkHalis Kaan · AkturkHalis Kaan
The Clinical Impact of GLP-1 Receptor Agonists in Type 2 Diabetes: Focus on the Long-Acting Analogs A MulvaneyShelagh · A MulvaneyShelagh · VaalaSarah · K HoodKorey · LybargerCindy · CarrollRachel · WilliamsLaura · C SchmidtDouglas · JohnsonKevin · S DietrichMary · LaffelLori · LaffelLori
Risk Factors of Hypoglycemia in Patients with Type 2 Diabetes Mellitus: A Study Based on Continuous Glucose Monitoring Robert H. Slover · Jeanie B. Tryggestad · Linda A. DiMeglio · Larry A. Fox · Bruce W. Bode · Timothy S. Bailey · Ronald L. Brazg · Mark P. Christiansen · Jennifer L. Sherr · Eva Tsalikian · Kevin Kaiserman · Ashley Sullivan · Suiying Huang · John H. Shin · Scott Lee · Francine R. Kaufman · Francine R. Kaufman
Human Subcutaneous Tissue Response to Glucose Sensors: Macrophages Accumulation Impact on Sensor Accuracy Stuart Little · Lalantha Leelarathna · Emma Walkinshaw · Hk Tan · O Chapple · Alexandra Lubina-Solomon · Thomas Chadwick · Shalleen Barendse · Deborah D. Stocken · Catherine Brennand · Sally M. Marshall · Ruth Wood · Jane Speight · David Kerr · Daniel Flanagan · Heller · Marc Evans · Shaw Ja · Shaw Ja
Plasma Insulin Levels and Hypoglycemia Affect Subcutaneous Interstitial Glucose Concentration Rikke Mette Agesen · Peter Kristensen · Henning Beck-Nielsen · Henning Beck-Nielsen · Kirsten Nørgaard · Hans Perrild · Tonny Jensen · Hans Henrik Parving · Hans Henrik Parving · Birger Thorsteinsson · Lise Tarnow · Lise Tarnow · Ulrik Pedersen-Bjergaard · Ulrik Pedersen-Bjergaard
Strategy for Mitigating DKA Risk in Patients with Type 1 Diabetes on Adjunctive Treatment with SGLT Inhibitors: A STICH Protocol P StoneMichael · AgrawalPratik · ChenXiaoxiao · LiuMargaret · ShinJohn · L CorderoToni · R KaufmanFrancine · R KaufmanFrancine
Study of MiniMed 640G Insulin Pump with SmartGuard in Prevention of Low Glucose Events in Adults with Type 1 Diabetes (SMILE): Design of a Hypoglycemia Prevention Trial with Continuous Glucose Monitoring Data as Outcomes Michael A. Wood · Dorothy I. Shulman · Gregory P. Forlenza · Bruce W. Bode · Orit Pinhas-Hamiel · Bruce Buckingham · Kevin B. Kaiserman · David R. Liljenquist · Timothy S. Bailey · John H. Shin · Suiying Huang · Xiaoxiao Chen · Toni L. Cordero · Scott Lee · Francine R. Kaufman · Francine R. Kaufman
Effects of Dapagliflozin on 24-Hour Glycemic Control in Patients with Type 2 Diabetes: A Randomized Controlled Trial Rahat Maitland · Nashita Patel · Suzanne Barr · Christina Sherry · Barbara Marriage · Paul Seed · Llenalia Garcia Fernandez · Jose M. Lopez Pedrosa · Helen R. Murphy · Ricardo Rueda · Lucilla Poston · Lucilla Poston
Ranting in 2018: Are We Making Progress? NambamBimota · BratinaNatasa · SchatzDesmond · SchatzDesmond
Accuracy, User Acceptability, and Safety Evaluation for the FreeStyle Libre Flash Glucose Monitoring System When Used by Pregnant Women with Diabetes Lia Bally · Hood Thabit · Hood Thabit
Anti-Insulin Antibodies and Adverse Events with Biosimilar Insulin Lispro Compared with Humalog Insulin Lispro in People with Diabetes MajidiShideh · FoutsAlexandra · PyleLaura · ChambersChristina · ArmstrongTaylor · WangZhenyuan · BatishSat Dev · KlingensmithGeorgeanna · K SteckAndrea · K SteckAndrea
Relevance of Bolus Calculators in Current Hybrid Closed Loop Systems P ForlenzaGregory · P ForlenzaGregory
Effect of Dapagliflozin on Glycemic Control, Weight, and Blood Pressure in Patients with Type 2 Diabetes Attending a Specialist Endocrinology Practice in Canada: A Retrospective Cohort Analysis E BrownRuth · GuptaNikhil · AronsonRonnie · AronsonRonnie
A Pediatric Intensive Care Unit Bedside Computer Clinical Decision Support Protocol for Hyperglycemia Is Feasible, Safe and Offers Advantages L HirshbergEliotte · J LanspaMichael · L WilsonEmily · A SwardKatherine · JephsonAl · Y LarsenGitte · H MorrisAlan · H MorrisAlan
Importance of artificial pancreas standard nomenclature BasuAnanda · BasuAnanda
Targeting One-Hour Postmeal Glucose: Is It Time for a Paradigm Switch in Diabetes Management? CerielloAntonio · CerielloAntonio
Expanding Treatment Options for Improving Health Outcomes in Type 1 Diabetes K GargSatish · K GargSatish
Self-Monitoring of Blood Glucose in Patients with Type 2 Diabetes Before and After Initiating Basal Insulin Treatment in China LuoYingying · BaoYuqian · ZhangPuhong · ZhuDongshan · LiXian · JiJiachao · ZhangHeng · JiLinong · JiLinong · JiLinong
Acceptance of FGM or CGM in Clinical Decision-Making and Patient Preference: Where Do We Go from Here? S MazzeRoger · S MazzeRoger
Hypoglycemia Risk Related to Double Dose Is Markedly Reduced with Basal Insulin Peglispro Versus Insulin Glargine in Patients with Type 2 Diabetes Mellitus in a Randomized Trial: IMAGINE 8 HarrisCynthia · ForstThomas · HeiseTim · Plum-MörschelLeona · WatkinsElaine · ZhangQianyi · FanLudi · GarhyanParag · PorksenNiels · PorksenNiels
The Effects of Basal Insulin Suspension at the Start of Exercise on Blood Glucose Levels During Continuous Versus Circuit-Based Exercise in Individuals with Type 1 Diabetes on Continuous Subcutaneous Insulin Infusion ZaharievaDessi · YavelbergLoren · JamnikVeronica · CinarAli · TurksoyKamuran · C RiddellMichael · C RiddellMichael
A Fixed Ratio Combination of Insulin Degludec and Liraglutide (IDegLira) Reduces Glycemic Fluctuation and Brings More Patients with Type 2 Diabetes Within Blood Glucose Target Ranges B KingAllen · Philis-TsimikasAthena · S KilpatrickEric · H LangbakkeIrene · BegtrupKamilla · VilsbøllTina · VilsbøllTina
Continuous Glucose Monitoring in Patients with Type 1 Diabetes and Impaired Awareness of Hypoglycemia: Also Effective in Patients with Psychological Distress? A J van BeersCornelis · de WitMaartje · J KleijerSusanne · H Geelhoed-DuijvestijnPetronella · DeVriesJ. Hans · H H KramerMark · DiamantMichaela · H SernéErik · J SnoekFrank · J SnoekFrank
Stability of Commercially Available Glucagon Formulation for Dual-Hormone Artificial Pancreas Clinical Use TalebNadine · CoriatiAdèle · KhazzakaChristian · BayonneJonathan · MessierVirginie · Rabasa-LhoretRémi · Rabasa-LhoretRémi
Automated Insulin Delivery System Nomenclature CohenOhad · A VigerskyRobert · W LeeScott · L CorderoToni · R KaufmanFrancine · R KaufmanFrancine
Assessment of Interday Glucose Variability in Type 2 Diabetes DadlaniVikash · C KudvaYogish · C KudvaYogish
Minimizing Glycemic Fluctuations in Patients with Type 2 Diabetes: Approaches and Importance DandonaParesh · DandonaParesh
An Amperometric Glucose Sensor Integrated into an Insulin Delivery Cannula: In Vitro and In Vivo Evaluation WardW. Kenneth · HeinrichGabriel · BreenMatthew · BenwareSheila · VollumNicole · MorrisKristin · KnutsenChad · D KowalskiJoseph · CampbellScott · BiehlerJerry · S VreekeMark · M VanderwerfScott · R CastleJessica · S CargillRobert · S CargillRobert
Continuous Glucose Monitoring in 2016 W BodeBruce · BattelinoTadej · BattelinoTadej
Effects of Sodium Glucose Cotransporter-2 Inhibitors on Serum Uric Acid in Type 2 Diabetes Mellitus AhmadiehHala · AzarSami · AzarSami
Re: Castle, et al., 2017; Diabetes Technol Ther; DOI: 10.1089/dia.2017.0012 R KaufmanFrancine · ShinJohn · ShinJohn
Efficacy and Safety of Biosimilar* SAR342434 Insulin Lispro in Adults with Type 1 Diabetes Also Using Insulin Glargine—SORELLA 1 Study K GargSatish · Wernicke-PantenKarin · RojeskiMaria · PierreSuzanne · KirchheinYvonne · JedynastyKrystyna · JedynastyKrystyna
Evaluation of Accuracy of Six Blood Glucose Monitoring Systems and Modeling of Possibly Related Insulin Dosing Errors BaumstarkAnnette · JendrikeNina · PleusStefan · HaugCornelia · FreckmannGuido · FreckmannGuido
FlexTouch: An Insulin Pen-Injector with a Low Activation Force Across Different Insulin Formulations, Needle Technologies, and Temperature Conditions GudiksenNiels · HofstätterThibaud · B RønnBirgitte · SparreThomas · SparreThomas
Accuracy of a Fourth-Generation Subcutaneous Continuous Glucose Sensor P ChristiansenMark · K GargSatish · BrazgRonald · W BodeBruce · S BaileyTimothy · H SloverRobert · SullivanAshley · HuangSuiying · ShinJohn · W LeeScott · R KaufmanFrancine · R KaufmanFrancine
Simulation-Based Evaluation of Dose-Titration Algorithms for Rapid-Acting Insulin in Subjects with Type 2 Diabetes Mellitus Inadequately Controlled on Basal Insulin and Oral Antihyperglycemic Medications MaXiaosu · Y ChienJenny · JohnsonJennal · MaloneJames · SinhaVikram · SinhaVikram
Advances in Subcutaneous Glucose Sensing Jessica R. Castle · Jessica R. Castle
An Expert Opinion on Advanced Insulin Pump Use in Youth with Type 1 Diabetes W BodeBruce · R KaufmanFrancine · VintNan · VintNan
Coverage of Prandial Insulin Requirements: An Elusive Goal HeinemannLutz · MuchmoreDouglas · MuchmoreDouglas
Investigating Hypoglycemic Confidence in Type 1 and Type 2 Diabetes H PolonskyWilliam · FisherLawrence · HesslerDanielle · V EdelmanSteven · V EdelmanSteven
Impact of a Paper-Based Dynamic Insulin Infusion Protocol on Glycemic Variability, Time in Target, and Hypoglycemic Risk: A Stepped Wedge Trial in Medical Intensive Care Unit Patients ClergeauAntoine · ParientiJean-Jacques · ReznikYves · ClergeauDeborah · SeguinAmelie · ValetteXavier · du CheyronDamien · JoubertMichael · JoubertMichael
Let the Algorithm Do the Work: Reduction of Hypoglycemia Using Sensor-Augmented Pump Therapy with Predictive Insulin Suspension (SmartGuard) in Pediatric Type 1 Diabetes Patients BiesterTorben · KordonouriOlga · HolderMartin · RemusKerstin · Kieninger-BaumDorothee · WadienTanja · DanneThomas · DanneThomas
Improved Algorithm for Automated Glucose Clamps KuhlenkötterMareike · HeiseTim · BeneschCarsten · BeneschCarsten
Role of Devices in Insulin Delivery F MeneghiniLuigi · McNultyJacqueline Nicole · McNultyJacqueline Nicole
mHealth Intervention Elements and User Characteristics Determine Utility: A Mixed-Methods Analysis A NelsonLyndsay · A MulvaneyShelagh · B JohnsonKevin · Y OsbornChandra · Y OsbornChandra
Comparison of Insulin Pump Therapy and Multiple Daily Injections Insulin Regimen in Patients with Type 1 Diabetes During Ramadan Fasting AlamoudiReem · AlsubaieeMaram · AlqarniAli · SalehYousef · AljaserSaleh · SalamAbdul · EledrisiMohsen · EledrisiMohsen
Long-Term Efficacy and Safety of Sensor Augmented Insulin Pump Therapy with Low-Glucose Suspend Feature in Patients with Type 1 Diabetes GómezAna María · Marín CarrilloLisseth Fernanda · Muñoz VelandiaOscar Mauricio · Rondón SepúlvedaMartín Alonso · M Arévalo CorreaCarol · Mora GarzónEdwin · Cuervo DiazMaria Camila · Henao CarrilloDiana Cristina · Henao CarrilloDiana Cristina
Clinical Experience with U-500 Regular Insulin by Multiple Daily Injections and Continuous Subcutaneous Insulin Infusion T MeadeLisa · C TartRebecca · NuzumDonnie · NuzumDonnie
Mobile health (mHealth) for diabetes care: opportunities and challenges Farhad Fatehi · Leonard C. Gray · Anthony W. Russell · Anthony W. Russell
In-Home Closed Loop Control for Artificial Pancreas: Patient and Provider Perspective EkhlaspourLaya · M MaahsDavid · M MaahsDavid
Learning Can Improve the Blood Glucose Control Performance for Type 1 Diabetes Mellitus WangYouqing · ZhangJinping · ZengFanmao · WangNa · ChenXiaoping · ZhangBo · ZhaoDong · YangWenying · CobelliClaudio · CobelliClaudio
Type 1 Diabetes at High Altitude: Performance of Personal Insulin Pumps and Patient Metabolic Control MatejkoBartłomiej · GawreckiAndrzej · WróbelMarta · HohendorffJerzy · Benbenek-KlupaTeresa · T MaleckiMaciej · Zozulińska-ZiółkiewiczDorota · KlupaTomasz · KlupaTomasz
Unintended Insulin Pump Delivery in Hyperbaric Conditions BertuzziFederico · PintaudiBasilio · BonomoMatteo · GarutiFabio · GarutiFabio
Challenges of Diabetes Management in Toddlers DeebAsma · DeebAsma
Reexamining the Hypoglycemia Fear Survey for Parents of Young Children in a Sample of Children Using Insulin Pumps R PattonSusana · E NoserAmy · A ClementsMark · M DolanLawrence · W PowersScott · W PowersScott
Efficacy and Safety of Insulin Therapy in Patients with Type 2 Diabetes Treated at Different Grades of Hospitals in China: Subgroup Analysis of the Real-World SEAS Study GuanXiaoling · MuYiming · ZhouXiaojun · ChenShaohua · DongJianjun · LiaoLin · LiaoLin
The Relationship Between Brown Adipose Tissue Content in Supraclavicular Fat Depots and Insulin Sensitivity in Patients with Type 2 Diabetes Mellitus and Prediabetes KoksharovaEkaterina · UstyuzhaninDmitry · PhilippovYury · MayorovAlexander · ShestakovaMarina · ShariyaMerab · TernovoySergey · DedovIvan · DedovIvan
Ranting in 2017: Is It Working? B HirschIrl · B HirschIrl
Neurological Changes in Hypoglycemia RubegaMaria · SparacinoGiovanni · SparacinoGiovanni
Administration of Biosimilar Insulin Analogs: Role of Devices HeinemannLutz · FritzIngo · KhatamiHootan · V EdelmanSteven · V EdelmanSteven
Retrofitting Real-Life Dexcom G5 Data FaveroSimone Del · FacchinettiAndrea · SparacinoGiovanni · CobelliClaudio · CobelliClaudio
Improved Postprandial Glycemic Control with Faster-Acting Insulin Aspart in Patients with Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion W BodeBruce · A JohnsonJoseph · HyveledLiselotte · C TamerSøren · DemissieMarek · DemissieMarek
Lipohypertrophy in China: Prevalence, Risk Factors, Insulin Consumption, and Clinical Impact JiLinong · SunZilin · LiQifu · QinGuijun · WeiZheng · LiuJunhao · B ChandranArthi · J HirschLaurence · J HirschLaurence
Feasibility of Long-Term Closed-Loop Control: A Multicenter 6-Month Trial of 24/7 Automated Insulin Delivery KovatchevBoris · ChengPeiyao · M AndersonStacey · E PinskerJordan · BoscariFederico · A BuckinghamBruce · DoyleFrancis J.Iii · K HoodKorey · A BrownSue · D BretonMarc · ChernavvskyDaniel · C BevierWendy · K BradleyPaige · BruttomessoDaniela · Del FaveroSimone · CaloreRoberta · CobelliClaudio · AvogaroAngelo · T LyTrang · ShanmughamSatya · DassauEyal · KollmanCraig · W LumJohn · W BeckRoy · W BeckRoy
The Use of Electrochemiluminescence Assays to Predict Autoantibody and Glycemic Progression Toward Type 1 Diabetes in Individuals with Single Autoantibodies M SosenkoJay · YuLiping · S SkylerJay · P KrischerJeffrey · A GottliebPeter · BoulwareDavid · MiaoDongmei · P PalmerJerry · K SteckAndrea · K SteckAndrea
Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes K GargSatish · A WeinzimerStuart · V TamborlaneWilliam · A BuckinghamBruce · W BodeBruce · S BaileyTimothy · L BrazgRonald · IlanyJacob · H SloverRobert · M AndersonStacey · M BergenstalRichard · GrosmanBenyamin · RoyAnirban · L CorderoToni · ShinJohn · W LeeScott · R KaufmanFrancine · R KaufmanFrancine
Will the First Approved Automated Insulin Delivery System Be a Game-Changer in Type 1 Diabetes Management? R CastleJessica · R CastleJessica
Are changes in heart rate variability during hypoglycemia confounded by the presence of cardiovascular autonomic neuropathy in patients with diabetes Simon Lebech Cichosz · Jan Frystyk · Lise Tarnow · Jesper Fleischer · Jesper Fleischer
DTT: 19 Years and Counting … K GargSatish · K GargSatish
Handling Exercise During Closed Loop Control D BretonMarc · D BretonMarc
Patient Inputs for Mobile Health Systems for Type 1 Diabetes Care KerrDavid · AxelrodCeara · HoppeCharis · HoppeCharis
High Glucose Variability in Hospitalized Patients with Type 1 Diabetes Mellitus B HirschIrl · B HirschIrl
Altered Patterns of Early Metabolic Decompensation in Type 1 Diabetes During Treatment with a SGLT2 Inhibitor: An Insulin Pump Suspension Study DadlaniVikash · U TamhaneShrikant · SunAidong · SharmaAnu · A DelivanisDanae · ThapaPrabin · E CarterRicky · C KudvaYogish · C KudvaYogish
Development of an Automatic Puncturing and Sampling System for a Self-Monitoring Blood Glucose Device S PatelNeha · A Van NameMichelle · CengizEda · R CarriaLori · A WeinzimerStuart · V TamborlaneWilliam · L SherrJennifer · L SherrJennifer
Type 1 Diabetes and Long-Term Continuous Subcutaneous Insulin Infusion Therapy: A 10-Year Experience from Macedonia MoraPablo · BuskirkAnn · LydenMaureen · G ParkinChristopher · BorsaLena · PetersenBettina · PetersenBettina
Detailed Analysis of Insulin Absorption Variability and the Tissue Response to Continuous Subcutaneous Insulin Infusion Catheter Implantation in Swine PetrovskiGoran · ZivkovicMarija · StratrovaSlavica Subeska · TodorovaBiljana Jovanovska · TodorovaBiljana Jovanovska
The Use of Mobile Applications Among Adults with Type 1 and Type 2 Diabetes: Results from the Second MILES—Australia (MILES-2) Study R HauzenbergerJasmin · R HipszerBrian · LoeumChanny · A McCuePeter · DeStefanoMark · C TorjmanMarc · T KanerMahmut · R DinesenAlek · ChervonevaInna · R PieberThomas · JosephJeffrey I · JosephJeffrey I
Challenges in Choosing a Medication for Type 2 Diabetes TrawleySteven · BaptistaShaira · L BrowneJessica · PouwerFrans · SpeightJane · SpeightJane
Venous, Arterialized-Venous, or Capillary Glucose Reference Measurements for the Accuracy Assessment of a Continuous Glucose Monitoring System Rodríguez-GutiérrezRene · Salcido-MontenegroAlejandro · Elizondo-PlazasAnasofia · González-GonzálezJosé Gerardo · González-GonzálezJosé Gerardo
Immune Interventions for Type 1 Diabetes Mellitus NambamBimota · BratinaNatasa · SchatzDesmond · SchatzDesmond
Predictive Low-Glucose Suspend to Prevent Hypoglycemia E PinskerJordan · DassauEyal · DassauEyal
Pregnancy Outcomes and Insulin Requirements in Women with Type 1 Diabetes Treated with Continuous Subcutaneous Insulin Infusion and Multiple Daily Injections: Cohort Study Sally K. Abell · Matthew Suen · Anthony Pease · Jacqueline Boyle · Georgia Soldatos · John Regan · Euan M. Wallace · Helena Teede · Helena Teede
Insulin Infusion Sets and Continuous Glucose Monitoring Sensors: Where the Artificial Pancreas Meets the Patient P ForlenzaGregory · P ForlenzaGregory
Type 1 Diabetes in the Hospital: What Do We Know About Glucose Control? E PinskerJordan · E SchoenbergBenjamen · GareyColleen · RunionAsher · LarezArianna · KerrDavid · KerrDavid
Perspectives on Long-Distance Air Travel with Type 1 Diabetes CampinosCatherine · Le FlochJean-Pierre · PetitCatherine · PenfornisAlfred · WiniszewskiPatrice · BordierLyse · LepageMarie · FermonCatherine · LouisJacques · AlmainCatherine · MorelDidier · HirschLaurence · W StraussKenneth · W StraussKenneth
An Effective Intervention for Diabetic Lipohypertrophy: Results of a Randomized, Controlled, Prospective Multicenter Study in France ZhangTingting · JiLinong · GaoYan · ZhangPuhong · ZhuDongshan · LiXian · JiJiachao · ZhaoFang · ZhangHeng · GuoXiaohui · GuoXiaohui
Application of Glycemic Variability Percentage: Implications for Continuous Glucose Monitor Utilization and Analysis of Artificial Pancreas Data GildersleeveRachel · L RiggsSara · R CherñavvskyDaniel · D BretonMarc · D DeBoerMark · D DeBoerMark
Self-Monitoring of Blood Glucose K GargSatish · B HirschIrl · B HirschIrl
Technology and Pregnancy HadarEran · A StewartZoe · HodMoshe · R MurphyHelen · R MurphyHelen
Real-World Challenges of Controller Adaptation with the Artificial Pancreas K GargSatish · K GargSatish
Modeling Subcutaneous Absorption of U100 and U300 Insulin Glargine in Type 1 Diabetes RodbardDavid · RodbardDavid
Complex Assessment of Metabolic Effectiveness of Insulin Pump Therapy in Patients with Type 2 Diabetes Beyond HbA1c Reduction AcciaroliGiada · VettorettiMartina · FacchinettiAndrea · SparacinoGiovanni · SparacinoGiovanni
Improving the Safety and Functionality of an Artificial Pancreas System for Use in Younger Children: Input from Parents and Physicians PearsonSam Matthew · A AjjanRamzi · A AjjanRamzi
Will Biosimilar Insulins Be Cheaper L LitchmanMichelle · A AllenNancy · D ColicchioVanessa · E WawrzynskiSarah · M SparlingKerri · L HendricksKrissa · A BergCynthia · A BergCynthia
Observational Registry of Basal Insulin Treatment in Patients with Type 2 Diabetes in China: Safety and Hypoglycemia Predictors MisraAnoop · MukherjeeRupali · LuthraAtul · SinghPadam · SinghPadam
Impact of an Automated Bihormonal Delivery System on Psychosocial Outcomes in Adults with Type 1 Diabetes L CorderoToni · K GargSatish · BrazgRonald · S BaileyTimothy · ShinJohn · W LeeScott · R KaufmanFrancine · R KaufmanFrancine
Evaluation of a New Digital Automated Glycemic Pattern Detection Tool Weissberg-BenchellJill · HesslerDanielle · FisherLawrence · J RussellSteven · H PolonskyWilliam · H PolonskyWilliam
Contribution of Structured Self-Monitoring of Blood Glucose to the Glycemic Control and the Quality of Life in Both Insulin- and Noninsulin-Treated Patients with Poorly Controlled Diabetes BallyLia · ThabitHood · ThabitHood
Rising Costs of Drug/Insulin Treatment for Diabetes: A Perspective from India KanKai · ZhuWei · LuFengdi · ShenYun · GaoFei · MoYifei · HeXingxing · BaoYuqian · ZhouJian · JiaWeiping · JiaWeiping
Incorporation of Models of CGM Sensor Error and Faults Affecting CGM Sensors in the UVA/Padova Type-1 Diabetic Simulator: Assessment on Clinical Data Yenny Leal · S. Del Favero · Martina Vettoretti · Roberto Visentin · Andrea Facchinetti · Claudio Cobelli · Claudio Cobelli
The First Hybrid Closed-Loop Insulin Pump: Will It Meet Its Potential? B HirschIrl · B HirschIrl
Why Do Some Concentrated Insulins Maintain Their Pharmacokinetics/Pharmacodynamics Profile? C HoodRobert · C HoodRobert
Factory-Calibrated Continuous Glucose Sensors: The Science Behind the Technology HossUdo · BudimanErwin Satrya · BudimanErwin Satrya
Metrics Beyond Hemoglobin A1C in Diabetes Management: Time in Range, Hypoglycemia, and Other Parameters WrightLorena Alarcon-Casas · B HirschIrl · B HirschIrl
Stability, Accuracy, and Risk Assessment of a Novel Subcutaneous Glucose Sensor HughesJonathan · B WelshJohn · C BhavarajuNaresh · J VanslykeStephen · K BaloAndrew · K BaloAndrew
Continuous Glucose Monitoring with Multiple Daily Insulin Treatment: Outcome Studies B McGillJanet · AhmannAndrew · AhmannAndrew
CGM, Pregnancy, and Remote Monitoring PolskySarit · GarcettiRachel · GarcettiRachel
Practical Considerations on the Use of Continuous Glucose Monitoring in Pediatrics and Older Adults and Nonadjunctive Use P ForlenzaGregory · B ArgentoNicholas · M LaffelLori · M LaffelLori
Continuous Glucose Monitoring and Global Reimbursement: An Update GrahamClaudia · GrahamClaudia
Severe Hypoglycemia Before Landing in a Patient with Type 1 Diabetes Using Sensor-Augmented Pump Therapy ViñalsClara · PanéAdriana · QuirósCarmen · GiménezMarga · CongetIgnacio · CongetIgnacio
Continuous Glucose Monitoring: A Review of Recent Studies Demonstrating Improved Glycemic Outcomes RodbardDavid · RodbardDavid
A Simple Composite Metric for the Assessment of Glycemic Status from Continuous Glucose Monitoring Data: Implications for Clinical Practice and the Artificial Pancreas B HirschIrl · K BaloAndrew · SayerKevin · GarciaArturo · A BuckinghamBruce · A PeyserThomas · A PeyserThomas
Bolus Calculator Reduces Hypoglycemia in the Short Term and Fear of Hypoglycemia in the Long Term in Subjects with Type 1 Diabetes (CBMDI Study) Vallejo MoraMaría del Rosario · CarreiraMónica · AnarteMaría Teresa · LinaresFrancisca · OlveiraGabriel · González RomeroStella · González RomeroStella
Future of Automated Insulin Delivery Systems Jessica R. Castle · J. Hans DeVries · Boris P. Kovatchev · Boris P. Kovatchev
Randomized Controlled Trial of Technology-Assisted Case Management in Low-Income Adults with Type 2 Diabetes E EgedeLeonard · S WilliamsJoni · C VoroncaDelia · G KnappRebecca · K FernandesJyotika · K FernandesJyotika
Clinical Implications of Accuracy Measurements of Continuous Glucose Sensors S BaileyTimothy · S BaileyTimothy
The Future of Continuous Glucose Monitoring K GargSatish · K AkturkHalis · K AkturkHalis
To Pump or Not to Pump in Pregnancy A StewartZoe · R MurphyHelen · R MurphyHelen
Performance of an Artificial Pancreas System for Young Children with Type 1 Diabetes D DeBoerMark · D BretonMarc · WakemanChristian · M SchertzElaine · G EmoryEmma · L RobicJessica · L KollarLaura · P KovatchevBoris · R CherñavvskyDaniel · R CherñavvskyDaniel
Evaluation of a Predictive Low-Glucose Management System In-Clinic A BuckinghamBruce · S BaileyTimothy · ChristiansenMark · GargSatish · WeinzimerStuart · BodeBruce · M AndersonStacey · BrazgRonald · T LyTrang · R KaufmanFrancine · R KaufmanFrancine
Efficacy and Safety of Insulin Glargine 300 U/mL Versus Insulin Glargine 100 U/mL in High-Risk and Low-Risk Patients with Type 2 Diabetes Stratified Using Common Clinical Performance Measures LingvayIldiko · ChaoJason · R DalalMehul · F MeneghiniLuigi · F MeneghiniLuigi
Outpatient Closed-Loop Control with Unannounced Moderate Exercise in Adolescents Using Zone Model Predictive Control M HuyettLauren · T LyTrang · P ForlenzaGregory · Reuschel-DiVirgilioSuzette · H MesserLaurel · WadwaR. Paul · GondhalekarRavi · DoyleFrancis J.Iii · E PinskerJordan · M MaahsDavid · A BuckinghamBruce · DassauEyal · DassauEyal
Accuracy Evaluation of Four Blood Glucose Monitoring Systems in the Hands of Intended Users and Trained Personnel Based on ISO 15197 Requirements FreckmannGuido · BaumstarkAnnette · JendrikeNina · RittmeyerDelia · PleusStefan · HaugCornelia · HaugCornelia
Closed-Loop Control of Postprandial Glycemia Using an Insulin-on-Board Limitation Through Continuous Action on Glucose Target RossettiPaolo · QuirósCarmen · MoscardóVanessa · ComasAnna · GiménezMarga · Ampudia-BlascoF. Javier · LeónFabián · MontaserEslam · CongetIgnacio · BondiaJorge · VehíJosep · VehíJosep
A Clinical Trial of the Accuracy and Treatment Experience of the Flash Glucose Monitor FreeStyle Libre in Adults with Type 1 Diabetes Arndís Finna Ólafsdóttir · Stig Attvall · Ulrika Sandgren · Sofia Dahlqvist · Aldina Pivodic · Stanko Skrtic · Elvar Theodorsson · Marcus Lind · Marcus Lind
How Can We Realize the Clinical Benefits of Continuous Glucose Monitoring A AjjanRamzi · A AjjanRamzi
Clinical Use of Continuous Glucose Monitoring in Pediatrics A LalRayhan · M MaahsDavid · M MaahsDavid
Artificial Pancreas in Young Children A Ohman-HansonRebecca · P ForlenzaGregory · P ForlenzaGregory
Flash Glucose Monitoring: The Future Is Here K GargSatish · AkturkHalis Kaan · AkturkHalis Kaan
Effectiveness of SmartGuard Technology in the Prevention of Nocturnal Hypoglycemia After Prolonged Physical Activity PetruzelkovaLenka · PickovaKlara · SumnikZdenek · SoupalJan · ObermannovaBarbora · ObermannovaBarbora
Behavioral Patterns and Associations with Glucose Control during 12-Week Randomized Free-Living Clinical Trial of Day and Night Hybrid Closed-Loop Insulin Delivery in Adults with Type 1 Diabetes Ali Emami · Malgorzata E. Willinska · Hood Thabit · Hood Thabit · Lalantha Leelarathna · Sara Hartnell · Sibylle Dellweg · Carsten Benesch · Julia K. Mader · Manuel Holzer · Harald Kojzar · Thomas R. Pieber · Sabine Arnolds · Mark L. Evans · Mark L. Evans · Roman Hovorka · Roman Hovorka
Insulin Pump Use in Young Children with Type 1 Diabetes: Sociodemographic Factors and Parent-Reported Barriers V CommissariatPersis · T BoyleClaire · M MillerKellee · G MantravadiManasa · J DeSalvoDaniel · V TamborlaneWilliam · A Van NameMichelle · J AndersonBarbara · A DiMeglioLinda · M LaffelLori · M LaffelLori
Effect of Linagliptin Versus Metformin on Glycemic Variability in Patients with Impaired Glucose Tolerance González-HerediaTonatiuh · M Hernández-CoronaDiana · González-OrtizManuel · Martínez-AbundisEsperanza · Martínez-AbundisEsperanza
Closed-Loop Control Without Meal Announcement in Type 1 Diabetes M CameronFaye · T LyTrang · A BuckinghamBruce · M MaahsDavid · P ForlenzaGregory · J LevyCarol · LamDavid · ClintonPaula · H MesserLaurel · WestfallEmily · LevisterCamilla · XieYan Yan · BaysalNihat · HowsmonDaniel · D PatekStephen · BequetteB. Wayne · BequetteB. Wayne
Maternal–Fetal Outcomes in 34 Pregnant Women with Type 1 Diabetes in Sensor-Augmented Insulin Pump Therapy GómezAna María · Marín CarrilloLisseth Fernanda · M Arévalo CorreaCarol · Muñoz VelandiaOscar Mauricio · Rondón SepúlvedaMartín Alonso · Silva HerreraJaime Luis · Henao CarrilloDiana Cristina · Henao CarrilloDiana Cristina
Glucose Exposure and Variability with Empagliflozin as Adjunct to Insulin in Patients with Type 1 Diabetes: Continuous Glucose Monitoring Data from a 4-Week, Randomized, Placebo-Controlled Trial (EASE-1) Susanne Famulla · Thomas R. Pieber · Jens Eilbracht · Dietmar Neubacher · Nima Soleymanlou · Hans J. Woerle · Uli C. Broedl · Stefan Kaspers · Stefan Kaspers
Individually Adaptive Artificial Pancreas in Subjects with Type 1 Diabetes: A One-Month Proof-of-Concept Trial in Free-Living Conditions Mirko Messori · Jort Kropff · Simone Del Favero · Jerome Place · Roberto Visentin · Roberta Calore · Chiara Toffanin · Federico Di Palma · Giordano Lanzola · Anne Farret · Federico Boscari · Silvia Galasso · Angelo Avogaro · Patrick Keith-Hynes · Boris P. Kovatchev · Daniela Bruttomesso · Lalo Magni · J. Hans DeVries · Eric Renard · Claudio Cobelli · Claudio Cobelli
Hypoglycemia-Associated EEG Changes Following Antecedent Hypoglycemia in Type 1 Diabetes Mellitus Anne-Sophie Sejling · Troels Wesenberg Kjaer · Troels Wesenberg Kjaer · Troels Wesenberg Kjaer · Ulrik Pedersen-Bjergaard · Line Sofie Remvig · Christian Seerup Frandsen · Linda Hilsted · Jens Faber · Jens Faber · Jens J. Holst · Lise Tarnow · Lise Tarnow · Jakob Skadkær Møller · Martin N. Nielsen · Birger Thorsteinsson · Claus Bogh Juhl · Claus Bogh Juhl
Real-World Use and Self-Reported Health Outcomes of a Patient-Designed Do-it-Yourself Mobile Technology System for Diabetes: Lessons for Mobile Health M LeeJoyce · W NewmanMark · GebremariamAchamyeleh · ChoiPreciosa · LewisDana · NordgrenWeston · CostikJohn · WeddingJames · WestBenjamin · GilbyNancy Benovich · HannemannChristopher · PasekJosh · GarrityAshley · HirschfeldEmily · HirschfeldEmily
Use of a Novel, Remotely Connected Diabetes Management System Is Associated with Increased Treatment Satisfaction, Reduced Diabetes Distress, and Improved Glycemic Control in Individuals with Insulin-Treated Diabetes: First Results from the Personal Diabetes Management Study Abe-DoiMari · OeMakoto · MurayamaRyoko · TakahashiMami · ZushiYasunobu · TanabeHidenori · TakamotoIseki · SuzukiRyo · YamauchiToshimasa · KadowakiTakashi · KomiyamaChieko · SanadaHiromi · SanadaHiromi
A Multicenter Real-Life Study on the Effect of Flash Glucose Monitoring on Glycemic Control in Patients with Type 1 and Type 2 Diabetes KropffJort · C van SteenSigrid · deGraaffPeter · W ChanMan · B E van AmstelRombout · DeVriesJ. Hans · DeVriesJ. Hans
The Durability of Basal Insulin Affects Day-to-Day Glycemic Variability Assessed by Continuous Glucose Monitoring in Type 2 Diabetes Patients: A Randomized Crossover Trial IuchiHiroyuki · SakamotoMasaya · MatsutaniDaisuke · SuzukiHirofumi · HoriuchiRyuzo · UtsunomiyaKazunori · UtsunomiyaKazunori
The Effect of Prior Continuous Glucose Monitoring Use on Glycemic Outcomes in the Pivotal Trial of the MiniMed™ 670G Hybrid Closed-Loop System G ParkinChristopher · HombergAnita · HinzmannRolf · HinzmannRolf
Real-World Challenges of Controller Adaptation with the Artificial Pancreas Melinda J. Hutchesson · Megan E. Rollo · Rebecca A. Krukowski · Louisa J Ells · Jean Harvey · Philip J. Morgan · Robin Callister · Ronald C. Plotnikoff · Clare E. Collins · Clare E. Collins
Faster Use and Fewer Failures with Needle-Free Nasal Glucagon Versus Injectable Glucagon in Severe Hypoglycemia Rescue: A Simulation Study YaleJean-François · DuludeHélène · EgethMarc · A PichéClaude · LafontaineMartin · CarballoDolorès · MargoliesRebecca · DissingerEmily · R ShamesAdam · KaplowitzNicole · ZhangMichelle Xiaotian · ZhangShuyu · B GuzmanCristina · B GuzmanCristina
Impact of continuous subcutaneous insulin infusion on diabetes related complications and associated costs in type 2 diabetes patients in sweden S Roze · E. Duteil · Alexis Delbaere · S. de Portu · A. S Brandt · Jarl Hellman · Anders Frid · Anders Frid
A mobile health intervention for self-management and lifestyle change for persons with type 2 diabetes, part 2 Heidi Holmen · Astrid Torbjørnsen · Astrid Klopstad Wahl · Anne Karen Jenum · Milada Cvancarova Småstuen · Eirik Årsand · Lis Ribu · Lis Ribu
Neonatal hypoglycemia continuous glucose monitoring: a randomized controlled trial in preterm infants A Galderisi · A Facchinetti · Gm Steil · P Ortiz-Rubio · C Cobelli · D Trevisanuto · D Trevisanuto
9th Annual Symposium on Self-Monitoring of Blood Glucose, April 28-30, 2016, Madrid, Spain HomePhilip · DerwahlKarl-Michael · ZiemenMonika · Wernicke-PantenKarin · PierreSuzanne · KirchheinYvonne · K GargSatish · K GargSatish
Contrasting the clinical care and outcomes of 2,622 children with type 1 diabetes less than 6 years of age in the United States T1D Exchange and German/Austrian DPV registries Dpv Initiative · Dpv Initiative
An intervention with a person-centered program, guided self-determination-young, in groups of adolescents starting on insulin pump : a randomized controlled trial Martina Vettoretti · Andrea Facchinetti · Giovanni Sparacino · Claudio Cobelli · Claudio Cobelli
Non-Adjunctive Use of CGM in T1D Therapy: In Silico Assessment of Using Glucose Trend Information for Insulin Dosing E PinskerJordan · J Laguna SanzAlejandro · LeeJoon Bok · ChurchMei Mei · AndreCamille · E LindseyLaura · J DoyleFrancis · DassauEyal · DassauEyal · DassauEyal
Using Digital Health Technology to Prevent and Treat Diabetes Neal Kaufman · Irina Khurana · Irina Khurana
Impact of Meal Constituents on Artificial Pancreas Algorithms Enrique Campos-Náñez · Boris P. Kovatchev · Boris P. Kovatchev
Web-Based Management Trial of Diabetes Care Katharine Barnard · Amanda Blatch-Jones · Amanda Blatch-Jones
Closing the Loop NimriRevital · MurrayNathan · OchsAlexander · E PinskerJordan · DassauEyal · DassauEyal
Low-dose otelixizumab anti-CD3 monoclonal antibody DEFEND-1 study: Results of the randomized phase III study in recent-onset human type 1 diabetes Ronnie Aronson · Peter A. Gottlieb · Jens Sandahl Christiansen · Thomas Donner · Emanuele Bosi · Bruce W. Bode · Paolo Pozzilli · Paolo Pozzilli
Minimally Disruptive Diabetes Care for the Elderly Gabriela Spencer-Bonilla · Rene Rodriguez-Gutierrez · Rene Rodriguez-Gutierrez · Victor M. Montori · Victor M. Montori
The Effects of Aging on Hemoglobin A1c Levels—The Potential Role of the Glycemic Gap Sindura Alloju · Sunder Mudaliar · Sunder Mudaliar
Comment onThe Performance and Usability of a Factory-Calibrated Flash Glucose Monitoring Systemby Bailey et al FreckmannGuido · PleusStefan · SchlüterSandra · HeinemannLutz · HeinemannLutz
Opportunities and Challenges of Telemedicine FrontinoGiulio · MeschiFranco · RigamontiAndrea · FavalliValeria · BonuraClara · BonfantiRiccardo · BonfantiRiccardo
Development of a New Tool to Assess Bolus Calculation and Carbohydrate Estimation Dominic Ehrmann · Norbert Hermanns · A Reimer · Jörg Weißmann · Thomas Haak · B Kulzer · B Kulzer
Self-Monitoring Using Continuous Glucose Monitors with Real-Time Feedback Improves Exercise Adherence in Individuals with Impaired Blood Glucose: A Pilot Study Kaitlyn J. Bailey · Jonathan P. Little · Mary E. Jung · Mary E. Jung
Continuous Glucose Monitoring: A Review of Successes, Challenges, and Opportunities David Rodbard · David Rodbard
Expert Study: Utility of an Automated Bolus Advisor System in Patients with Type 1 Diabetes Treated with Multiple Daily Injections of Insulin—A Crossover Study Cintia Gonzalez · María José Picón · Monica Tomé · Isabel Pujol · José Carlos Fernández-García · Ana Chico · Ana Chico
Modeling Transient Disconnections and Compression Artifacts of Continuous Glucose Sensors FacchinettiAndrea · Del FaveroSimone · SparacinoGiovanni · CobelliClaudio · CobelliClaudio
The Impact of a Clinical Decision Support System in Diabetes Primary Care Patients in a Developing Country MaiaJúnia Xavier · de SousaLidiane Aparecida Pereira · MarcolinoMilena Soriano · CardosoClareci Silva · da SilvaJosé Luiz Padilha · AlkmimMaria Beatriz Moreira · RibeiroAntonio Luiz Pinho · RibeiroAntonio Luiz Pinho
Continuous Glucose Monitoring in 2015 BattelinoTadej · W BodeBruce · W BodeBruce
Reimbursement for Continuous Glucose Monitoring Lutz Heinemann · J. Hans DeVries · J. Hans DeVries
Use of a Computer-Based Insulin Infusion Algorithm to Treat Diabetic Ketoacidosis in the Emergency Department Jagdeesh Ullal · Raymie McFarland · Margaret Bachand · Joseph A. Aloi · Joseph A. Aloi
Ranting in 2016: A Medical System in Crisis B HirschIrl · B HirschIrl
The Impact of Continuous Subcutaneous Insulin Infusion Therapy on Efficacy and Safety in a Cohort of Type 1 Diabetes Patients: A 3-Year Prospective Study Andreas Melidonis · Alexandros V. Kamaratos · Angeliki Angelidi · Petros Thomakos · Spiridon Vrakas · John Bakalis · Evangelos Fousteris · Stella Iraklianou · Stella Iraklianou
Immune Intervention in Type 1 Diabetes NambamBimota · BratinaNatasa · SchatzDesmond · SchatzDesmond
Direct Evidence of Acetaminophen Interference with Subcutaneous Glucose Sensing in Humans: A Pilot Study BasuAnanda · VeettilSona · DyerRoy · PeyserThomas · BasuRita · BasuRita
Continuous Glucose Monitoring, Future Products, and Update on Worldwide Artificial Pancreas Projects Jort Kropff · J. Hans DeVries · J. Hans DeVries
Improved Accuracy of Continuous Glucose Monitoring Systems in Pediatric Patients with Diabetes Mellitus: Results from Two Studies LaffelLori · LaffelLori
Diabetes and partners Katharine Barnard · Jill Weissberg-Benchell · Jill Weissberg-Benchell
Considerations in Using Serious Videogames as a Method for Providing Diabetes Education A DriscollKimberly · A DriscollKimberly
Best Ways and Practices to Avoid Insulin Pump Catheter Occlusions Robert H. Slover · Robert H. Slover
Limitations of Continuous Glucose Monitor Usage Henry Anhalt · Henry Anhalt
Access to and interest in using smartphone technology for the management of type 1 diabetes in ethnic minority adolescents and their parents St. GeorgeSara M. · M DelamaterAlan · R PulgaronElizabeth · DaigreAmber · SanchezJanine · SanchezJanine
A Review of Nutritional Tracking Mobile Applications for Diabetes Patient Use Alaina Darby · M. Strum · Erin R. Holmes · Justin Gatwood · Justin Gatwood
Effect of Metformin on Fibroblast Growth Factor-21 Levels in Patients with Newly Diagnosed Type 2 Diabetes Hui Fan · XiaoMeng Sun · Heng Zhang · Jia Liu · Pengrui Zhang · Yuan Xu · QingRong Pan · Guang Wang · Guang Wang
Insulin Infusion Sets: A Critical Reappraisal Lutz Heinemann · Lutz Heinemann
Comparison of Different Models of Structured Self-Monitoring of Blood Glucose in Type 2 Diabetes Ching-Lu Li · Yueh-Chu Wu · Edy Kornelius · Yu-Ju Chen · Yu-Tze Lin · Huei-Wen Hsiao · Chiung-Huei Peng · Yi-Sun Yang · Chien-Ning Huang · Chien-Ning Huang
DTT: 18 Years and Counting… Satish K. Garg · Satish K. Garg
Type 2 Diabetes Management Algorithms WangnooSubhash Kumar · WangnooSubhash Kumar
New Insulins, Biosimilars, and Insulin Therapy DanneThomas · HeinemannLutz · BolinderJan · BolinderJan
Clinical Application of the Food Insulin Index for Mealtime Insulin Dosing in Adults with Type 1 Diabetes: A Randomized Controlled Trial Kirstine J. Bell · Robyn Gray · Diane Munns · Peter Petocz · Garry M. Steil · Gabrielle Howard · Stephen Colagiuri · Jennie Brand-Miller · Jennie Brand-Miller
Using Digital Health Technology to Prevent and Treat Diabetes KaufmanNeal · SalahiAyten · SalahiAyten
The Future of Glucose Monitoring Satish K. Garg · Satish K. Garg
Prevention of Hypoglycemia Using the Predicted Low Glucose Suspend System ChaseH. Peter · ChaseH. Peter
Cost-Effectiveness of Sensor-Augmented Pump Therapy with Low Glucose Suspend Versus Standard Insulin Pump Therapy in Two Different Patient Populations with Type 1 Diabetes in France RozeStéphane · Smith-PalmerJayne · ValentineWilliam · PayetVincent · de PortuSimona · PapoNatalie · CucheratMichel · HanaireHélène · HanaireHélène
Hypoglycemia-Induced Decrease of EEG Coherence in Patients with Type 1 Diabetes Maria Rubega · Giovanni Sparacino · Anne Sophie Sejling · Claus Bogh Juhl · Claudio Cobelli · Claudio Cobelli
Determinants of Glycemic Response to Add-On Therapy with a Dipeptidyl Peptidase-4 Inhibitor: A Retrospective Cohort Study Using a United Kingdom Primary Care Database Jil Mamza · Rajnikant Mehta · Richard Donnelly · Iskandar Idris · Iskandar Idris
Model-Based Quantification of Glucagon-Like Peptide-1–Induced Potentiation of Insulin Secretion in Response to a Mixed Meal Challenge Dalla ManChiara · MichelettoFrancesco · SathananthanMatheni · VellaAdrian · CobelliClaudio · CobelliClaudio
Glycemic Index of a Novel High-Fiber White Rice Variety Developed in India—A Randomized Control Trial Study MohanViswanathan · AnjanaRanjit Mohan · GayathriRajgopal · Ramya BaiMookambika · LakshmipriyaNagrajan · RuchiVaidya · JakirM. Mohamed · ShobanaShanmugam · UnnikrishnanRanjit · KrishnaswamyKamala · HenryJeya Kumar · SudhaVasudevan · SudhaVasudevan
Upcoming Trends for Inpatient Diabetes Management ClementStephen · ClementStephen
Reduced Silent Occlusions with a Novel Catheter Infusion Set (BD FlowSmart): Results from Two Open-Label Comparative Studies Michael Gibney · Zhenyi Xue · Monica Swinney · Damian Bialonczyk · Laurence Hirsch · Laurence Hirsch
Utilization of a Cloud-Based Diabetes Management Program for Insulin Initiation and Titration Enables Collaborative Decision Making Between Healthcare Providers and Patients William C. Hsu · Ka Hei Karen Lau · Ruyi Huang · Suzanne Ghiloni · Hung M. Le · Scott Gilroy · Martin J. Abrahamson · John B. Moore · John B. Moore
Advances in Exercise, Physical Activity, and Diabetes Mellitus M PasiekaAoibhe · C RiddellMichael · C RiddellMichael
Diabetes Technology and the Human Factor LibermanAlon · BarnardKatharine · BarnardKatharine
Mealtime Insulin Dosing by Carbohydrate Counting in Hospitalized Cardiology Patients: A Retrospective Cohort Study Kristina M. Thurber · Ross A. Dierkhising · Sarah A. Reiland · Kristina K. Pearson · Steven A. Smith · Steven A. Smith
β-Cell Function and Insulin Sensitivity in Normal Glucose-Tolerant Subjects Stratified by 1-Hour Plasma Glucose Values M PriyaMiranda · AmuthaAnandakumar · RanjaniHarish · JebaraniSaravanan · GokulakrishnanKuppan · PradeepaRajendra · UnnikrishnanRanjit · AnjanaRanjit Mohan · MohanViswanathan · MohanViswanathan
Insulin Pumps in Type 1 Diabetes with Mental Disorders: Real-Life Clinical Data Indicate Discrepancies to Recommendations PrinzNicole · BächleChristina · BeckerMarianne · BergerGabriele · GallerAngela · HaberlandHolger · MeusersMichael · MirzaJoaquina · L PlenerPaul · von SengbuschSimone · ThieneltMichaela · W HollReinhard · W HollReinhard
Use of Telemedicine to Improve Adherence to American Diabetes Association Standards in Pediatric Type 1 Diabetes L WoodColleen · A ClementsScott · McFannKim · SloverRobert · F ThomasJohn · F ThomasJohn · WadwaR. Paul · WadwaR. Paul
Impact of a Serious Videogame Designed for Flexible Insulin Therapy on the Knowledge and Behaviors of Children with Type 1 Diabetes: The LUDIDIAB Pilot Study JoubertMichael · ArmandColine · MoreraJulia · TokayevaLeyla · GuillaumeAurore · ReznikYves · ReznikYves
Opportunities and Challenges of Telemedicine: Observations from the Wild West in Pediatric Type 1 Diabetes Elisa Giani · Lori Laffel · Lori Laffel
Can Diabetes Management Be Done Effectively Through the Cloud Eric Renard · Eric Renard
Comment on Publications from OpT2mise Study MilenkovicTatjana · KocovaMirjana · KrstevskaBrankica · PemovskaGordana · SmokovskiIvica · SmokovskiIvica
Accuracy of Continuous Glucose Monitoring in Patients After Total Pancreatectomy with Islet Autotransplantation P ForlenzaGregory · M NathanBrandon · MoranAntoinette · B DunnTy · J BeilmanGregory · L PruettTimothy · P KovatchevBoris · D BellinMelena · D BellinMelena
Response to Letter to the Editor Regarding OpT2mise Study Ignacio Conget · Ronnie Aronson · Ohad Cohen · Yves Reznik · Yves Reznik
Response to the Comment onThe Performance and Usability of a Factory-Calibrated Flash Glucose Monitoring Systemby Bailey et al Timothy S. Bailey · Shridhara Alva · Bruce W. Bode · Mark P. Christiansen · Leslie J. Klaff · Leslie J. Klaff
Normative Values for Electrochemical Skin Conductances and Impact of Ethnicity on Quantitative Assessment of Sudomotor Function Aaron I. Vinik · A. Gordon Smith · J. Robinson Singleton · Brian C. Callaghan · Barry I. Freedman · Jaakko Tuomilehto · L. Bordier · B. Bauduceau · Frédéric Roche · Frédéric Roche
Emotional Distress in the Partners of Type 1 Diabetes Adults: Worries About Hypoglycemia and Other Key Concerns William H. Polonsky · Lawrence Fisher · Danielle Hessler · Nicole Johnson · Nicole Johnson
Are patients with diabetes mellitus satisfied with technologies used to assist with diabetes management and coping Sheelah Harrison · Marietta Stadler · Khalida Ismail · Stephanie A. Amiel · A. Herrmann-Werner · A. Herrmann-Werner
Comparison Between HDL-C Levels in Argentine Indigenous Children Living at High Altitudes and U.S. Children HirschlerValeria · GonzalezClaudio · MaccalliniGustavo · HidalgoMariana · MolinariClaudia · MolinariClaudia
Study of Insulin Requirement Modeling in Hospitalized Elderly Patients with Type 2 Diabetes at a Late Stage of Stepwise Escalation Therapy Afshan Nourizadeh-Sedaghati · Michel Herbin · Céline Lukas-Croisier · Jean-Luc Novella · B. Delemer · B. Delemer
Variation in point-of-care testing of HbA1c in diabetes care general practice Troels Kristensen · Troels Kristensen
Hypoglycemia Prevention and User Acceptance of an Insulin Pump System with Predictive Low Glucose Management Pratik Choudhary · Birthe S. Olsen · Ignacio Conget · John B. Welsh · Linda Vorrink · John J. Shin · John J. Shin
Association of Diabetic Microvascular Complications and Parameters of Obstructive Sleep Apnea in Patients with Type 2 Diabetes Rui Zhang · Puhong Zhang · Fang Zhao · Xueyao Han · Linong Ji · Linong Ji
A Study of the Carbohydrate-to-Insulin Ratio in Pregnant Women with Type 1 Diabetes on Pump Treatment BongiovanniMarzia · FresaRaffaella · VisalliNatalia · BittermanOlimpia · SuraciConcetta · NapoliAngela · NapoliAngela
Insulin Pump Malfunction During Hospitalization: Two Case Reports R FauldsEileen · L WyneKathleen · O BuschurElizabeth · McDanielJodi · DunganKathleen · DunganKathleen
Role of Automation/Technology in Day-to-Day Diabetes Care DadlaniVikash · C KudvaYogish · C KudvaYogish
Direct Evidence of Acetaminophen Interference with Subcutaneous Glucose Sensing in Humans: A Pilot Study Ananda Basu · Sona Veettil · Roy B. Dyer · Thomas A. Peyser · Rita Basu · Rita Basu
Possible Radio Interference Between Video Capsule Endoscopy and Second-Generation OmniPod Patch Pump Dario Pitocco · Alessandro Rizzi · Annalisa Tortora · Andrea Manto · Francesco Zaccardi · Giovanni Ghirlanda · Guido Costamagna · Maria Elena Riccioni · Maria Elena Riccioni
Insulin Pump Failures: Has There Been an Improvement? Update of a Prospective Observational Study Agathe Guenego · Guillaume Bouzillé · Stéphanie Breitel · Annabelle Esvant · Jean-Yves Poirier · Fabrice Bonnet · Isabelle Guilhem · Isabelle Guilhem
The Use of Mobile Applications Among Adolescents with Type 1 Diabetes: Results from Diabetes MILES Youth—Australia Steven Trawley · Jessica L. Browne · Virginia Hagger · Christel Hendrieckx · Elizabeth Holmes-Truscott · Frans Pouwer · Timothy Chas Skinner · Jane Speight · Jane Speight
Ranting in 2016: A Medical System in Crisis Irl B. Hirsch · Irl B. Hirsch
A Relevant Glucose-Insulin Model: Validation using Clinical Data Nicolas Magdelaine · Lucy Chaillous · Isabelle Guilhem · Jean-Yves Poirier · Fournier-Guilloux Anne-Laure · Michel Krempf · Claude H. Moog · Eric Le Carpentier · Eric Le Carpentier
Effect of lipohypertrophy on accuracy of continuous glucose monitoring in patients with type 1 diabetes D.J. DeSalvo · David M. Maahs · Laurel Messer · R.P. Wadwa · S. Payne · Trang T. Ly · Bruce Buckingham · Bruce Buckingham
Direct Evidence of Acetaminophen Interference with Subcutaneous Glucose Sensing in Humans Ananda Basu · Sona Veettil · Roy B. Dyer · Thomas A. Peyser · Rita Basu · Rita Basu
Wavelets for CGM off-line Denoising Nicolas Magdelaine · Lucy Chaillous · Isabelle Guilhem · Jean-Yves Poirier · Michel Krempf · Fournier-Guilloux Anne-Laure · Claude H. Moog · Claude H. Moog
High-Throughput Screening in General Population for Type 1 Diabetes ZhaoZhiyuan · YuLiping · YuLiping
Pokémon Go, Obesity and Diabetes: A Perspective from India GhoshAmerta · MisraAnoop · MisraAnoop
Perceptions and experiences of using automated bolus advisors amongst people with type 1 diabetes: A longitudinal qualitative investigation Julia Lawton · Jackie Kirkham · David W. H. Rankin · Katharine Barnard · Cindy Cooper · Carolin Taylor · Simon Heller · Jackie Elliott · Jackie Elliott
New Insulins, Biosimilars, and Insulin Therapy Thomas Danne · Lutz Heinemann · Jan Bolinder · Jan Bolinder
CGM Retrospective Data Analysis Gary Scheiner · Gary Scheiner
Interstitial Fluid Glucose Is Not Just a Shifted-in-Time but a Distorted Mirror of Blood Glucose: Insight from an In Silico Study Claudio Cobelli · Michele Schiavon · Chiara Dalla Man · Ananda Basu · Rita Basu · Rita Basu
A Phytosterol-Enriched Spread Improves Lipid Profile and Insulin Resistance of Women with Gestational Diabetes Mellitus: A Randomized, Placebo-Controlled Double-Blind Clinical Trial LiQin · XingBaoheng · XingBaoheng
9th Annual Symposium on Self-Monitoring of Blood Glucose, April 28–30, 2016, Madrid, Spain G ParkinChristopher · HombergAnita · HinzmannRolf · HinzmannRolf
Premixed Insulin Analogue Compared with Basal-Plus Regimen for Inpatient Glycemic Control Gracia-RamosAbraham Edgar · Cruz-DomínguezMaría del Pilar · Madrigal-SantillánEduardo Osiris · Morales-GonzálezJosé Antonio · Madrigal-BujaidarEduardo · Aguilar-FaisalJosé Leopoldo · Aguilar-FaisalJosé Leopoldo
Minimization of Hypoglycemia as an Adverse Event During Insulin Infusion: Further Refinement of the Yale Protocol R MarvinMichael · E InzucchiSilvio · J BestermanBrian · J BestermanBrian
Cardiovascular Outcomes of New Medications for Type 2 Diabetes M TrujilloJennifer · A WettergreenSara · A NufferWesley · L EllisSamuel · T McDermottMichael · T McDermottMichael
Randomized Trial of Long-Acting Insulin Glargine Titration Web Tool (LTHome) Versus Enhanced Usual Therapy of Glargine Titration (INNOVATE Trial) S BajajHarpreet · VennKarri · YeChenglin · AronsonRonnie · AronsonRonnie
Selective IL-2 responsiveness of regulatory T Cells through multiple intrinsic mechanisms supports the use of low-dose IL-2 therapy in type 1 diabetes Aixin Yu · Isaac Snowhite · Francesco Vendrame · Michelle Rosenzwajg · D. Klatzman · Alberto Pugliese · T. R. Malek · T. R. Malek
Measures of Glycemic Variability in Type 1 Diabetes and the Effect of Real-Time Continuous Glucose Monitoring Ahmed H. El-Laboudi · Ian F. Godsland · Desmond G. Johnston · Nick Oliver · Nick Oliver
Hypoglycemia in Older Adults with Type 1 Diabetes N DuBoseStephanie · S WeinstockRuth · W BeckRoy · L PetersAnne · AleppoGrazia · M BergenstalRichard · RodriguezHenry · F LargayJoseph · M MassaroElaine · B HirschIrl · B HirschIrl
Clinical Outcomes After 1 Year of Augmented Insulin Pump Therapy in Patients with Diabetes in a Specialized Diabetes Center in Medellín, Colombia Ramirez-RinconAlex · Hincapie-GarcíaJaime · ArangoClaudia Monsalve · AristizabalNatalia · CastilloEstefany · HincapieGloria · ZapataEliana · CuestaDiana Paola · DelgadoMaria · AbadVeronica · TorresJose Luis · PalacioAndres · BoteroJosé Fernando · BoteroJosé Fernando
Mitigating Reductions in Glucose During Exercise on Closed-Loop Insulin Delivery: The Ex-Snacks Study S PatelNeha · A Van NameMichelle · CengizEda · R CarriaLori · M TichyEileen · WeymanKate · A WeinzimerStuart · V TamborlaneWilliam · L SherrJennifer · L SherrJennifer
Evaluation of Blood Glucose Meter Efficacy in an Antenatal Diabetes Clinic Rachel T. McGrath · Vanessa C. Donnelly · Sarah J. Glastras · Veronica Preda · Nisa Sheriff · Peter Ward · Samantha L. Hocking · Gregory R. Fulcher · Gregory R. Fulcher
Should GLP-1 Receptor Agonists Be the First Line of Treatment for Type 2 Diabetes? Richard E. Pratley · Richard E. Pratley
Predicting Insulin Treatment Scenarios with the Net Effect Method: Domain of Validity VettorettiMartina · FacchinettiAndrea · SparacinoGiovanni · CobelliClaudio · CobelliClaudio
Association of HbA1c to BOLUS Scores Among Youths with Type 1 Diabetes A ClementsMark · A ClementsMark · A ClementsMark · A DeLurgioStephen · D WilliamsDavid · HabibSana · R PattonSusana · R PattonSusana
Association Between Heart Rate Variability Measures and Blood Glucose Levels: Implications for Noninvasive Glucose Monitoring for Diabetes J RothbergLeon · LeesTy · Clifton-BlighRoderick · LalSara · LalSara
Effect of Electronic Messaging on Glucose Control and Hospital Admissions Among Patients with Diabetes PetulloBrian · NobleByron · M DunganKathleen · M DunganKathleen
Comparison of Different Treatment Modalities for Type 1 Diabetes, Including Sensor-Augmented Insulin Regimens, in 52 Weeks of Follow-Up: A COMISAIR Study ŠoupalJan · PetruželkováLenka · FlekačMilan · PelclTomáš · MatoulekMartin · DaňkováMartina · ŠkrhaJan · SvačinaŠtěpán · PráznýMartin · PráznýMartin
Role of Dual-Hormone Closed-Loop Delivery System in the Future Lia Bally · Hood Thabit · Roman Hovorka · Roman Hovorka
Does Reducing Basal Insulin During Ramadan Fasting by Children and Adolescents with Type 1 Diabetes Decrease the Risk of Symptomatic Hypoglycemia DeebAsma · Al QahtaniNabras · AttiaSalima · Al SuwaidiHana · NagelkerkeNico · NagelkerkeNico
Predictors of Renal Function Decline in Chinese Patients with Type 2 Diabetes Mellitus and in a Subgroup of Normoalbuminuria: A Retrospective Cohort Study Ping Hu · Xianghai Zhou · Xin Wen · Linong Ji · Linong Ji
Improved Insulin Pharmacokinetics Using a Novel Microneedle Device for Intradermal Delivery in Patients with Type 2 Diabetes KochbaEfrat · LevinYotam · RazItamar · CahnAvivit · CahnAvivit
Predictive Model for Estimating the Cost of Incident Diabetes Complications ZhuJia · KahnPeter · KnudsenJanine · N MehtaSanjeev · A GabbayRobert · A GabbayRobert
Acceptability of Robot Assistant in Management of Type 1 Diabetes in Children Majid A. Al-Taee · Ritika R Kapoor · Christopher Garrett · Pratik Choudhary · Pratik Choudhary
Genetic and Clinical Predictive Factors of Sulfonylurea Failure in Patients with Type 2 Diabetes Qian Ren · Di Xiao · Xueyao Han · Stacey L. Edwards · Huaiqing Wang · Yong Tang · Simin Zhang · Xi Li · Xiuying Zhang · Xiaoling Cai · Zhao-Qian Liu · Sanjoy K. Paul · Linong Ji · Linong Ji
The Role of a Coronary Artery Calcium Scan in Type 1 Diabetes R BurgeMark · EatonR. Philip · S SchadeDavid · S SchadeDavid
The Burden of Structured Self-Monitoring of Blood Glucose on Diabetes-Specific Quality of Life and Locus of Control in Patients with Noninsulin-Treated Type 2 Diabetes: The PRISMA Study T RussoGiuseppina · ScaviniMarina · AcmetElena · BonizzoniErminio · BosiEmanuele · GiorginoFrancesco · TiengoAntonio · CucinottaDomenico · CucinottaDomenico
Use of Glucose Rate of Change Arrows to Adjust Insulin Therapy Among Individuals with Type 1 Diabetes Who Use Continuous Glucose Monitoring Jeremy Pettus · Steven V. Edelman · Steven V. Edelman
Implications of Predictive Low-Glucose Management System in Hybrid of Full Closed Loop System ChoudharyPratik · ChoudharyPratik
Continuous Glucose Monitoring in 2015 Tadej Battelino · Bruce W. Bode · Bruce W. Bode
Comparison of Two Continuous Glucose Monitoring Systems, Dexcom G4 Platinum and Medtronic Paradigm Veo Enlite System, at Rest and During Exercise TalebNadine · EmamiAli · SuppereCorinne · MessierVirginie · LegaultLaurent · ChiassonJean-Louis · Rabasa-LhoretRémi · HaidarAhmad · HaidarAhmad
Continuous Glucose Monitor Use and Accuracy in Hospitalized Patients DadlaniVikash · C KudvaYogish · C KudvaYogish
From Two to One Per Day Calibration of Dexcom G4 Platinum by a Time-Varying Day-Specific Bayesian Prior Giada Acciaroli · Martina Vettoretti · Andrea Facchinetti · Giovanni Sparacino · Claudio Cobelli · Claudio Cobelli
CoYoT1 Clinic: Innovative Telemedicine Care Model for Young Adults with Type 1 Diabetes K RaymondJennifer · L BergetCari · A DriscollKimberly · KetchumKaitlin · CainCynthia · F “Fred” ThomasJohn · F “Fred” ThomasJohn
Effective Postprandial Glucose Management in Pregnancy with Type 1 Diabetes Sarit Polsky · Sarit Polsky
Automated Overnight Closed-Loop Control Using a Proportional-Integral-Derivative Algorithm with Insulin Feedback in Children and Adolescents with Type 1 Diabetes at Diabetes Camp T LyTrang · KeenanD. Barry · RoyAnirban · HanJino · GrosmanBenyamin · CantwellMartin · KurtzNatalie · von EybenRie · ClintonPaula · M WilsonDarrell · A BuckinghamBruce · A BuckinghamBruce
The Impact of Insulin Pump Therapy on Glycemic Profiles in Patients with Type 2 Diabetes: Data from the OpT2mise Study CongetIgnacio · CastanedaJavier · PetrovskiGoran · GuerciBruno · RacaultAnne-Sophie · ReznikYves · CohenOhad · RunzisSarah · de PortuSimona · AronsonRonnie · AronsonRonnie
Obstructive Sleep Apnea and Diabetic Nephropathy Anoop Misra · Usha Shrivastava · Usha Shrivastava
Duration of Infusion Set Survival in Lipohypertrophy Versus Nonlipohypertrophied Tissue in Patients with Type 1 Diabetes W KarlinAndrew · T LyTrang · PyleLaura · P ForlenzaGregory · MesserLaurel · WadwaR. Paul · J DeSalvoDaniel · L PayneSydney · HanesSarah · ClintonPaula · M MaahsDavid · BuckinghamBruce · BuckinghamBruce
A Simplified Semiquantitative Meal Bolus Strategy Combined with Single- and Dual-Hormone Closed-Loop Delivery in Patients with Type 1 Diabetes: A Pilot Study GingrasVéronique · HaidarAhmad · MessierVirginie · LegaultLaurent · LadouceurMartin · Rabasa-LhoretRémi · Rabasa-LhoretRémi
Immune Intervention in Type 1 Diabetes Bimota Nambam · Natasa Bratina · Desmond A. Schatz · Desmond A. Schatz
What Matters for Calculating Insulin Bolus Dose AnnanFrancesca · AnnanFrancesca
Patient-Centered Care, Glycemic Control, Diabetes Self-Care, and Quality of Life in Adults with Type 2 Diabetes S WilliamsJoni · J WalkerRebekah · L SmallsBrittany · HillRachel · E EgedeLeonard · E EgedeLeonard
Is Pump Therapy for All with Type 1 Diabetes M WilsonDarrell · M WilsonDarrell
Recovery of hypoglycemia awareness in longstanding type 1 diabetes: A multicenter 2×2 factorial randomized controlled trial comparing insulin pump with multiple daily injections and continuous with conventional glucose selfmonitoring (HypoCOMPaSS) D RiddlesworthTonya · W BeckRoy · L GalRobin · G ConnorCrystal · M BergenstalRichard · LeeSooji · M WilliSteven · M WilliSteven
ECL-IAA and ECL-GADA Can Identify High-Risk Single Autoantibody-Positive Relatives in the TrialNet Pathway to Prevention Study Andrea K. Steck · Alexandra Fouts · Dongmei Miao · Zhiyuan Zhao · Fran Dong · Jay M. Sosenko · Peter A. Gottlieb · Marian Rewers · Liping Yu · Liping Yu
INJECTION PAIN AND ANXIETY IN CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES: CAN AN INDWELLING CATHETER (I-PORT ADVANCE (R)) IMPROVE METABOLIC CONTROL AND QUALITY OF LIFE? Angela Zanfardino · Pasquale Villano · Santino Confetto · Alda Troncone · Elisabetta Caredda · Alessandra Cocca · Francesca Casaburo · L Russo · Alessia Piscopo · Crescenzo Cascella · Antonietta Chianese · M Giglio · Laura Perrone · Dario Iafusco · Dario Iafusco
Racial-ethnic disparities in management and outcomes among children with type 1 diabetes Steven M. Willi · Kellee M. Miller · Linda A. DiMeglio · Georgeanna J. Klingensmith · Jill H. Simmons · William V. Tamborlane · Kristen J. Nadeau · Julie M. Kittelsrud · Peter J. Huckfeldt · Roy W. Beck · Terri H. Lipman · Terri H. Lipman
DPP-4 Inhibitor Treatment in Chinese Type 2 Diabetes Patients: A Meta-Analysis CaiXiaoling · GaoXueying · YangWenjia · ChenYifei · ZhouLingli · ZhangSimin · HanXueyao · JiLinong · JiLinong
Physiology-Invariant Meal Detection for Type 1 Diabetes WeimerJames · ChenSanjian · PeleckisAmy · R RickelsMichael · LeeInsup · LeeInsup
The Influence of Family History Risk Levels of Diabetes on Disease Prevalence in a High-Risk Diabetic Chinese Population Xiujuan Du · Yinan Zhang · Fei Gao · Huijuan Lu · Yixie Shen · Ruihua Chen · Pingyan Fang · Yuqian Bao · Congrong Wang · Weiping Jia · Weiping Jia
Frequency of Missed Insulin Boluses in Type 1 Diabetes and Its Impact on Diabetes Control S JaserSarah · A DatyeKarishma · A DatyeKarishma
Impact of the Omnipod® Insulin Management System on Quality of Life: A Survey of Current Users H PolonskyWilliam · HesslerDanielle · E LayneJennifer · ZisserHoward · ZisserHoward
ANTIOXIDANT STATUS IN REPRODUCTIVE AGE WOMEN WITH DIABETES MELLITUS TYPE 1 L.I. Kolesnikova · S.I. Kolesnikov · Darenskaya · L.A. Grebenkina · N.V. Semenova · O.V. Vanteeva · O.V. Vanteeva
Effectiveness of Automated Insulin Management Features of the MiniMed® 640G Sensor-Augmented Insulin Pump Alex Zhong · Pratik Choudhary · Chantal M. Mcmahon · Pratik Agrawal · John B. Welsh · Toni L. Cordero · Francine R. Kaufman · Francine R. Kaufman
Efficacy and Tolerability of Exenatide Once Weekly Over 6 Years in Patients with Type 2 Diabetes: An Uncontrolled Open-Label Extension of the DURATION-1 Study Robert R. Henry · Eric J. Klein · Jenny Han · Nayyar Iqbal · Nayyar Iqbal
Human Factor Considerations for Artificial Pancreas Research A Gonder-FrederickLinda · H GrabmanJesse · A ShepardJaclyn · A ShepardJaclyn
EHealth interventions for the prevention and treatment of overweight and obesity in adults: A systematic review with meta-analysis ComellasMaría José · AlbiñanaEmma · ArtesMaite · CorcoyRosa · Fernández-GarcíaDiego · García-AlemánJorge · García-CuarteroBeatriz · GonzálezCintia · RiveroMaría Teresa · CasamiraNúria · WeissmannJörg · WeissmannJörg
Microneedle-array patches loaded with hypoxia-sensitive vesicles provide fast glucose-responsive insulin delivery N AdamsRebecca · L TanenbaumMolly · J HanesSarah · M AmbrosinoJodie · T LyTrang · T LyTrang · M MaahsDavid · NaranjoDiana · Walders-AbramsonNatalie · A WeinzimerStuart · A BuckinghamBruce · K HoodKorey · K HoodKorey
Decreased Glycemic Difference Between Diabetes and Nondiabetes in the Elderly Leads to the Reduced Diagnostic Accuracy of Hemoglobin A1c for Diabetes Screening in an Aged Chinese Population Xiantong Zou · Yufeng Li · Xiaoling Cai · Simin Zhang · Xiuying Zhang · Xueyao Han · Xianghai Zhou · Linong Ji · Linong Ji
Pathways Between Discrimination and Quality of Life in Patients with Type 2 Diabetes Obinna Achuko · Rebekah J. Walker · Jennifer A. Campbell · Aprill Z. Dawson · Leonard E. Egede · Leonard E. Egede
Dulce Wireless Tijuana: A Randomized Control Trial Evaluating the Impact of Project Dulce and Short-Term Mobile Technology on Glycemic Control in a Family Medicine Clinic in Northern Mexico Anzaldo-CamposMaría Cecilia · ContrerasSonia · Vargas-OjedaAdriana · Menchaca-DíazRufino · FortmannAddie · Philis-TsimikasAthena · Philis-TsimikasAthena
Evaluation of the Adherence to Continuous Glucose Monitoring in the Management of Type 1 Diabetes Patients on Sensor-Augmented Pump Therapy: The SENLOCOR Study Sylvie Picard · H. Hanaire · Sabine Baillot-Rudoni · Elisabeth Gilbert-Bonnemaison · Didier Not · Yves Reznik · Bruno Guerci · Bruno Guerci
Effect of Different Insulin Response Patterns During Oral Glucose Tolerance Test on Glycemia in Individuals with Normal Glucose Tolerance Edavan P. Praveen · Sunil Chouhan · Jayaprakash Sahoo · Sudhir K. Goel · Sada Nand Dwivedi · Madan L. Khurana · Bindu Kulshreshtha · Ariachery C. Ammini · Ariachery C. Ammini
Evaluation of a Nurse-Managed Insulin Infusion Protocol Andrea Passarelli · Haley Gibbs · Annette M. Rowden · Leigh Efird · Elizabeth K. Zink · Nestoras Mathioudakis · Nestoras Mathioudakis
Continuous Subcutaneous Insulin Infusion During Pregnancy in Women with Complicated Type 1 Diabetes Is Associated with Better Glycemic Control but Not with Improvement in Pregnancy Outcomes KekäläinenPäivi · JuutiMari · WalleTiina · LaatikainenTiina · LaatikainenTiina
Prevalence of Insulin Pump Therapy and Its Association with Measures of Glycemic Control: Results from the Canadian Study of Longevity in Type 1 Diabetes BouletGeneviève · M HalpernElise · E LovblomLeif · WeismanAlanna · BaiJohnny-Wei · EldelekliDevrim · A KeenanHillary · H BrentMichael · PaulNarinder · BrilVera · Z I CherneyDavid · A PerkinsBruce · A PerkinsBruce
Continuous Subcutaneous Insulin Infusion During Pregnancy in Women with Complicated Type 1 Diabetes Is Associated with Better Glycemic Control but Not with Improvement in Pregnancy Outcomes Päivi Kekäläinen · Mari Juuti · Tiina Walle · Tiina Laatikainen · Tiina Laatikainen
Efficacy and Safety of Flexible Versus Fixed Dosing Intervals of Insulin Glargine 300 U/mL in People with Type 2 Diabetes Matthew C. Riddle · Geremia B. Bolli · Philip Home · Richard M. Bergenstal · Monika Ziemen · Isabel Muehlen-Bartmer · Marek Wardecki · Laetitia Vinet · Nathalie Jeandidier · Hannele Yki-Järvinen · Hannele Yki-Järvinen
The application of discrete choice experiments in cost-effectiveness studies to assess the benefits of sensor-augmented insulin pump therapy for the treatment of type 1 diabetes N. Barnett · Elizabeth Geelhoed · Elizabeth A. Davis · Timothy W. Jones · M. De Bock · Gregory D. Smith · Richard Norman · Richard Norman
Effect of daily glucose fluctuation on coronary plaque vulnerability in patients pre-treated with lipid-lowering therapy: A prospective observational study Masaru Kuroda · Toshiro Shinke · Kazuhiko Sakaguchi · Hiromasa Otake · Tomofumi Takaya · Yushi Hirota · D. Sugiyama · Masayuki Nakagawa · Hirotoshi Hariki · Takumi Inoue · Tsuyoshi Osue · Yu Taniguchi · Masamichi Iwasaki · Ryo Nishio · Hiroto Kinutani · Akihide Konishi · Noritoshi Hiranuma · Hachidai Takahashi · Daisuke Terashita · K. Hirata · K. Hirata
Successful Performance of Laboratory Investigations with Blood Glucose Meters Employing a Dynamic Electrochemistry-Based Correction Algorithm Is Dependent on Careful Sample Handling Filiz Demircik · David C. Klonoff · Petra B. Musholt · Sanja Ramljak · Andreas Pfützner · Andreas Pfützner
PERCEIVED UTILITY OF A REMOTE MONITORING SYSTEM FOR PEDIATRIC SUBJECTS AFFECTED BY TYPE 1 DIABETES IN PEDARPAN (PEDIATRICS ARTIFICIAL PANCREAS) SUMMER CAMP E By:losiouk · Giordano Lanzola · Riccardo Bonfanti · Dario Iafusco · Ivana Rabbone · Alberto Sabbion · Riccardo Schiaffini · Alfonso Galderisi · Marco Marigliano · Novella Rapini · Andrea Rigamonti · Davide Tinti · Vallone · Angela Zanfardino · Federico Boscari · Silvia Galasso · Alda Troncone · S. Del Favero · Roberto Visentin · Roberta Calore · My Leal · F. Di Palma · Mirko Messori · Daniel Chernavvsky · L. Magni · Daniela Bruttomesso · Silvana Quaglini · Claudio Cobelli · Claudio Cobelli
Study of Glycemic Variability Through Time Series Analyses (Detrended Fluctuation Analysis and Poincaré Plot) in Children and Adolescents with Type 1 Diabetes García MasetLeonor · GonzálezLidia Blasco · FurquetGonzalo Llop · SuayFrancisco Montes · MarcoRoberto Hernández · MarcoRoberto Hernández
Reduction in CD4 central memory T-cell subset in costimulation modulator abatacept-treated patients with recent-onset type 1 diabetes is associated with slower C-peptide decline Tihamer Orban · Craig A. Beam · Ping Xu · K. Moore · Q. Jiang · J. Deng · Sarah Muller · Peter A. Gottlieb · Lisa M. Spain · Mark Peakman · Mark Peakman
NerveCheck for the Detection of Sensory Loss and Neuropathic Pain in Diabetes Georgios Ponirakis · Maria N Odriozola · Samantha Odriozola · Ioannis N. Petropoulos · Shazli Azmi · Maryam Ferdousi · Hassan Fadavi · Uazman Alam · Andrew Marshall · Maria Jeziorska · Anthony Miro · Ahmad Kheyami · Mitra Tavakoli · Ahmed Al-Ahmar · Maria B Odriozola · Ariel Odriozola · Rayaz A. Malik · Rayaz A. Malik
Insulin Infusion Set Use: European Perspectives and Recommendations DeissDorothee · AdolfssonPeter · Alkemade-van ZomerenMarije · B BolliGeremia · CharpentierGuillaume · CobelliClaudio · DanneThomas · GirelliAngela · MuellerHeiko · A VerdereseCarol · RenardEric · RenardEric
Improving Efficacy of Inhaled Technosphere Insulin (Afrezza) by Postmeal Dosing: In-silico Clinical Trial with the University of Virginia/Padova Type 1 Diabetes Simulator VisentinRoberto · GiegerichClemens · JägerRobert · DahmenRaphael · BossAnders · GrantMarshall · Dalla ManChiara · CobelliClaudio · KlabundeThomas · KlabundeThomas
Factors Affecting Recruitment of Participants for Studies of Diabetes Technology in Newly Diagnosed Youth with Type 1 Diabetes: A Qualitative Focus Group Study with Parents and Children Conor Farrington · Janet M. Allen · Martin Tauschmann · Tabitha Randell · Nicola Trevelyan · Roman Hovorka · Roman Hovorka
Clinical Safety and Feasibility of the Advanced Bolus Calculator for Type 1 Diabetes Based on Case-Based Reasoning: A 6-Week Nonrandomized Single-Arm Pilot Study Monika Reddy · Peter Pesl · Maria Xenou · Christofer Toumazou · D.A. Johnston · Pantelis Georgiou · Pau Herrero · Nick Oliver · Nick Oliver

Emerging Technologies for Diabetes Care
Diabetes Technology and Therapeutics | 2018
N ShahViral · M LaffelLori · WadwaR. Paul · K GargSatish · K GargSatish